<!DOCTYPE html> 
<html lang='en-US' xml:lang='en-US'> 
<head><title>2 Literature review</title> 
<meta charset='utf-8' /> 
<meta content='TeX4ht (https://tug.org/tex4ht/)' name='generator' /> 
<meta content='width=device-width,initial-scale=1' name='viewport' /> 
<link href='index.css' type='text/css' rel='stylesheet' /> 
<meta content='index.tex' name='src' /> 
 <script type='text/javascript' id='MathJax-script' src='https://cdn.jsdelivr.net/npm/mathjax@3/es5/mml-chtml.js' async='async'></script>  
 
<script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.7/latest.js?config=TeX-MML-AM_CHTML' type='text/javascript'></script> 
<script src='https://hypothes.is/embed.js' type='text/javascript'></script><link href='css/scale.css' type='text/css' rel='stylesheet' /></head><body>
   <!-- l. 221 --><div class='crosslinks'><p class='noindent'>[<a href='indexch3.html'>next</a>] [<a href='indexch1.html'>prev</a>] [<a href='indexch1.html#tailindexch1.html'>prev-tail</a>] [<a href='#tailindexch2.html'>tail</a>] [<a href='index.html#indexch2.html'>up</a>] </p></div>
   <h2 class='chapterHead'><span class='titlemark'>Chapter 2</span><br /><a id='x7-120002'></a>Literature review</h2>
   <div class='chapterTOCS'>
    <span class='sectionToc'>2.1 <a href='#x7-130002.1'>Introduction</a></span>
<br />    <span class='sectionToc'>2.2 <a href='#x7-140002.2'>Parkinson’s disease</a></span>
<br />     <span class='subsectionToc'>2.2.1 <a href='#x7-150002.2.1' id='QQ2-7-15'>Symptoms</a></span>
<br />     <span class='subsectionToc'>2.2.2 <a href='#x7-160002.2.2' id='QQ2-7-16'>Treatments</a></span>
<br />    <span class='sectionToc'>2.3 <a href='#x7-170002.3'>The basal ganglia</a></span>
<br />     <span class='subsectionToc'>2.3.1 <a href='#x7-180002.3.1' id='QQ2-7-20'>Projection patterns and pathways</a></span>
<br />     <span class='subsectionToc'>2.3.2 <a href='#x7-210002.3.2' id='QQ2-7-24'>Effects of dopamine depletion</a></span>
<br />     <span class='subsectionToc'>2.3.3 <a href='#x7-250002.3.3' id='QQ2-7-32'>Pathological firing patterns and oscillations</a></span>
<br />    <span class='sectionToc'>2.4 <a href='#x7-270002.4'>Mechanism of action of DBS</a></span>
<br />    <span class='sectionToc'>2.5 <a href='#x7-280002.5'>Approaches to computational modeling of the basal ganglia and DBS</a></span>
<br />     <span class='subsectionToc'>2.5.1 <a href='#x7-290002.5.1' id='QQ2-7-37'>Network models of pathological oscillations</a></span>
<br />     <span class='subsectionToc'>2.5.2 <a href='#x7-330002.5.2' id='QQ2-7-41'>Modeling DBS mechanisms of action</a></span>
<br />     <span class='subsectionToc'>2.5.3 <a href='#x7-400002.5.3' id='QQ2-7-48'>Limitations of computational models</a></span>
   </div>
   <h3 class='sectionHead'><span class='titlemark'>2.1   </span> <a id='x7-130002.1'></a>Introduction</h3>
<!-- l. 11 --><p class='noindent'>The underlying motivation for the research undertaken in this thesis is to improve the
outcomes of deep brain stimulation therapy for Parkinson’s disease. This requires
an understanding of the neurobiological underpinnings of the disease and the role
of deep brain stimulation, historically and within the course of treatment for PD
patients. To this end, the neuro-anatomical substrate for PD, the basal ganglia, and
the primary pathological features will first be introduced. They will be presented
both from a cellular/molecular perspective and from a network perspective, as local
physiological changes become manifest in aberrant network interactions reflected in
cognitive/behavioral symptoms. Insights into the mechanisms of DBS will also be
reviewed from both these perspectives, and finally it it shown how computational
modeling can bridge the gaps between these different ways of understanding the
disease.
                                                                                

                                                                                
</p><!-- l. 27 --><p class='noindent'>
</p>
   <h3 class='sectionHead'><span class='titlemark'>2.2   </span> <a id='x7-140002.2'></a>Parkinson’s disease</h3>
<!-- l. 34 --><p class='noindent'>Parkinson’s disease is a complex neurodegenerative disease that is difficult to diagnose in the
early stages and has distinct clinical manifestations across patients and over the
course of disease progression. It is associated with several motor and neuropsychiatric
symptoms <span class='cite'>[<a href='indexli5.html#Xjankovic_parkinsons_2008'>166</a>]</span>, with the primary motor symptoms characterized by muscular rigidity
leading to bradykinesia and akinesia, as well as tremor and postural instability.
These symptoms can become severely debilitating depending on the state of disease
progression, leading to a significant reduction in quality of life and high socio-economic
burden <span class='cite'>[<a href='indexli5.html#Xgustavsson2011cost'>136</a>, <a href='indexli5.html#Xwittchen2011size'>372</a>, <a href='indexli5.html#Xolesen2012economic'>268</a>]</span>.
</p><!-- l. 45 --><p class='indent'>   The root cause of Parkinsonism is the degeneration of dopamine-secreting neurons in the
substantia nigra pars compacta (SNc), one of the nuclei of the basal ganglia (BG),
which is triggered by both genetic and environmental factors <span class='cite'>[<a href='indexli5.html#Xkalia_parkinsons_2015'>171</a>]</span>. Because the SNc
innervates other structures in the basal ganglia, where the secreted dopamine serves
mainly as a neuromodulator regulating brain plasticity and cell excitability, the loss of
dopaminergic neurons leads to widespread structural and functional changes throughout
basal ganglia thalamo-cortical circuits. This has led Parkinson’s sisease to become
characterized as a network dysfunction <span class='cite'>[<a href='indexli5.html#Xmcintyre_network_2010'>240</a>]</span>. Indeed, the basal ganglia are a central
node in motor, associative, and limbic networks <span class='cite'>[<a href='indexli5.html#Xjahanshahi_frontostriatosubthalamicpallidal_2015'>163</a>]</span>. Its role has been associated
mainly with action selection and sequencing, and coordinating the interaction between
deliberate/goal-directed and habitual/automatic behaviors across cognitive domains. In
the latter role, the BG rewires itself using reinforcement learning with dopamine
functioning as a reward signal and is believed to subserve the learning or transfer of
slow, deliberate to fast automatic behaviors. This central and integrative nature of
the BG may explain the seemingly unrelated features of Parkinsonism which span
motor and mood disorders, problems with memory and attention, and inhibitory
control.
</p><!-- l. 66 --><p class='noindent'>
                                                                                

                                                                                
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.2.1   </span> <a id='x7-150002.2.1'></a>Symptoms</h4>
<!-- l. 77 --><p class='noindent'>The clinical features of Parkinson’s disease include both motor and non-motor symptoms.
Non-motor symptoms commonly occur in early PD, and before motor symptoms are manifest
<span class='cite'>[<a href='indexli5.html#Xpostuma_identifying_2012'>291</a>, <a href='indexli5.html#Xkhoo_spectrum_2013'>179</a>]</span>. They include sensory and sleep abnormalities, psychiatric symptoms, autonomic
dysfunction, pain and fatigue <span class='cite'>[<a href='indexli5.html#Xchaudhuri_non-motor_2006'>58</a>, <a href='indexli5.html#Xkhoo_spectrum_2013'>179</a>]</span>. The cardinal motor symptoms of PD are resting
tremor, muscular rigidity, bradykinesia/akinesia, postural instability and gait disturbances.
While these features occur in different combinations between patients, the consensus is that
there are two major clusters of symptoms, corresponding to PD subtypes <span class='cite'>[<a href='indexli5.html#Xmarras_parkinsons_2013'>230</a>]</span>. These
subtypes are tremor-dominant and non-tremor dominant PD, with the latter characterized
mainly by akinetic-bradykinetic symptoms, postural instability, and rigidity. The resting
tremor characteristic of tremor-dominant PD is often difficult to separate from essential
tremor, which is characterized more by kinetic and postural tremor <span class='cite'>[<a href='indexli5.html#Xbhidayasiri_differential_2005'>36</a>]</span>. Resting tremor
manifests itself in uncontrollable shaking mainly in the distal parts of the limbs (hands,
fingers, feet) and occurs within the frequency bands 4-6 Hz or 8-11 Hz <span class='cite'>[<a href='indexli5.html#Xkoller_tremors_1989'>186</a>, <a href='indexli5.html#Xmoustafa_motor_2016'>258</a>]</span>. While
symptoms falling in the two subtypes of PD are not correlated to each other <span class='cite'>[<a href='indexli5.html#Xlouis_clinical_2001'>215</a>]</span>,
tremor-dominant patients were found to transition to a mixed or akinesia dominant
phenotype in 15-28 %, respectively 46-50 % of cases <span class='cite'>[<a href='indexli5.html#Xvoncoelin_motor_2015'>363</a>]</span>. The bradykinesia and
akinesia characteristic of non-tremor-dominant PD is a slowness of movement or
inability to move that manifests itself both in the planning/initiation and execution
phase <span class='cite'>[<a href='indexli5.html#Xberardelli_pathophysiology_2001'>28</a>]</span>. Notably, its severity is dependent on emotional state and is reduced
when the patient is presented with an external trigger or cue, suggesting that motor
programs are intact but difficult to access <span class='cite'>[<a href='indexli5.html#Xjankovic_parkinsons_2008'>166</a>]</span>. Moreover, compared to tremor,
bradykinesia/akinesia and rigidity correlate more strongly with dopamine loss in the BG
<span class='cite'>[<a href='indexli5.html#Xalbin_functional_1989'>13</a>, <a href='indexli5.html#Xhelmich_cerebral_2012'>149</a>, <a href='indexli5.html#Xrodriguez-oroz_initial_2009'>307</a>]</span> and with pathological neuronal activity patterns in BG structures
characteristic of PD, such as increased beta-band oscillatory activity and bursting
<span class='cite'>[<a href='indexli5.html#Xmoran_subthalamic_2008'>254</a>, <a href='indexli5.html#Xsharott_activity_2014'>323</a>]</span>.
</p><!-- l. 112 --><p class='noindent'>
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.2.2   </span> <a id='x7-160002.2.2'></a>Treatments</h4>
<!-- l. 115 --><p class='noindent'>The primary treatment from Parkinson’s disease is dopamine replacement therapy in the form
                                                                                

                                                                                
of the dopamine precursor levodopa or dopaminergic agonists. However, chronic dopamine
replacement therapy typically introduces new symptoms such as levodopa-induces dyskinesias
and on-off state fluctuations where the responsiveness to medication and severity of
motor symptoms fluctuate over time. Deep brain stimulation (DBS) is a clinically
effective and safe alternative therapy to manage the motor symptoms of PD that
is most commonly prescribed under these circumstances, when pharmacological
treatment alone is no longer effective <span class='cite'>[<a href='indexli5.html#Xpizzolato_deep_2012'>286</a>, <a href='indexli5.html#Xbronstein_deep_2011'>41</a>, <a href='indexli5.html#Xweaver_bilateral_2009'>367</a>, <a href='indexli5.html#Xbenabid_deep_2009'>27</a>]</span>. However, the spectrum of
indications for DBS is expanding beyond resistance to pharmacological treatment to
early-stage motor symptoms of PD <span class='cite'>[<a href='indexli5.html#Xschuepbach_neurostimulation_2013'>318</a>, <a href='indexli5.html#Xhacker_deep_2015'>138</a>]</span> as well other neurological and psychiatric
disorders <span class='cite'>[<a href='indexli5.html#Xlyons_deep_2011'>217</a>, <a href='indexli5.html#Xkrack_deep_2010'>187</a>]</span> such as obsessive-compulsive disorder <span class='cite'>[<a href='indexli5.html#Xgreenberg_deep_2010'>128</a>]</span> and treatment-resistant
depression <span class='cite'>[<a href='indexli5.html#Xmayberg_deep_2005'>233</a>]</span>.
</p><!-- l. 133 --><p class='indent'>   DBS was developed initially as a safer and reversible alternative for the ablation (lesioning)
of deep brain structures and consists instead of chronic stimulation of these structures using
implanted electrodes. Continuous high-frequency stimulation is typically administered in the
STN or internal globus pallidus (GPi) for the treatment of Parkinsonian motor symptoms, or
in the thalamus specifically for treating tremor <span class='cite'>[<a href='indexli5.html#Xwichmann_deep_2016'>371</a>]</span>. The current clinical standard is
high-frequency DBS, where pulses are delivered continuously at a frequency between 130-180
Hz, on a patient-specific basis <span class='cite'>[<a href='indexli5.html#Xmoro_impact_2002'>256</a>, <a href='indexli5.html#Xtimmermann_ten-hertz_2004'>352</a>, <a href='indexli5.html#Xlimousin_effect_1995'>206</a>]</span>. However in recent years, adaptive stimulation
protocols have been trialled on patients and proven effective at improving motor symptoms
<span class='cite'>[<a href='indexli5.html#Xlittle_adaptive_2013'>210</a>, <a href='indexli5.html#Xcagnan_stimulating_2017'>53</a>]</span>, with potentially improved outcomes compared to continuous high-frequency
DBS <span class='cite'>[<a href='indexli5.html#Xlittle_adaptive_2016'>211</a>]</span>. Such adaptive protocols are event-driven, triggered by monitoring a
biomarker associated with motor symptoms such as oscillatory power in the local field
potential <span class='cite'>[<a href='indexli5.html#Xlittle_adaptive_2013'>210</a>]</span> or the phase of the tremor signal recorded using an accelerometer
<span class='cite'>[<a href='indexli5.html#Xcagnan_stimulating_2017'>53</a>]</span>.
</p><!-- l. 149 --><p class='indent'>   Besides DBS therapy, various forms of transcranial magnetic and electrical stimulation
(TMS; tES, respectively) were shown to be effective at improving Parkinsonian motor
symptoms <span class='cite'>[<a href='indexli5.html#Xgoodwill_using_2017'>124</a>]</span>. These stimulation modalities provide a potential non-invasive alternative to
DBS, which requires invasive surgery, and work by delivering electrical currents to brain tissue
directly or by inducing them indirectly through magnetic induction. Using repetitive
transcranial magnetic stimuation, both low-frequency (0.2 Hz, <span class='cite'>[<a href='indexli5.html#Xshimamoto_therapeutic_2001'>331</a>]</span>) and high-frequency (25
Hz, <span class='cite'>[<a href='indexli5.html#Xkhedr_effect_2006'>178</a>]</span>) stimulation protocols proved effective at improving motor symptoms. A
meta-analysis showed that tES was as effective as TMS at improving motor scores,
increasing potential clinical viability of due to reduced costs and size of the equipment
                                                                                

                                                                                
<span class='cite'>[<a href='indexli5.html#Xgoodwill_using_2017'>124</a>]</span>.
</p><!-- l. 161 --><p class='indent'>   Despite promising results of these alternative stimulation modalities in experimental
settings, DBS remains the standard of care, next to drug therapy, due to its effectiveness at
controlling symptoms and possibility chronic administration using an implantable pulse
generator. However, DBS therapy still has several important shortcomings. On average, it
offers only 40-50% improvement in motor symptoms as assessed by the unified Parkinson’s
disease rating scale (UPDRS) <span class='cite'>[<a href='indexli5.html#Xchen2006deep'>59</a>, <a href='indexli5.html#Xschuepbach_neurostimulation_2013'>318</a>]</span>. Moreover, the indications for DBS applied to targets
in the BG are primarily akinetic-bradykinetic symptoms and tremor whereas it is ineffective
for the treatment of axial symptoms such as freezing of gait, and for mood disturbances and
cognitive symptoms <span class='cite'>[<a href='indexli5.html#Xeisenstein_acute_2014'>92</a>, <a href='indexli5.html#Xmerola_impulse_2017'>245</a>]</span>. Although the scope of DBS is being expanded to other targets
in the brain to treat such symptoms <span class='cite'>[<a href='indexli5.html#Xthevathasan_pedunculopontine_2011'>351</a>]</span>, treatment is not yet clinically established as
the efficacy is not robust over time <span class='cite'>[<a href='indexli5.html#Xhuang_deep_2018'>159</a>]</span>. The development of tolerance to DBS is
not uncommon <span class='cite'>[<a href='indexli5.html#Xkumar_long-term_2003'>192</a>, <a href='indexli5.html#Xhoueto_failure_2000'>157</a>]</span>, necessitating frequent reprogramming of the stimulation
parameters which remains a largely empirical procedure, is costly, and time consuming.
Moreover, there is a range of stimulation-induced side effects with varying rate of
incidence, ranging from dyskinesias (involuntary movements) to mood disturbances
<span class='cite'>[<a href='indexli5.html#Xguehl_statistical_2007'>131</a>, <a href='indexli5.html#Xbenabid_deep_2009'>27</a>]</span>.
</p><!-- l. 183 --><p class='noindent'>
</p>
   <h3 class='sectionHead'><span class='titlemark'>2.3   </span> <a id='x7-170002.3'></a>The basal ganglia</h3>
<!-- l. 197 --><p class='noindent'>The basal ganglia consist of four subcortical nuclei of which the structure and interconnectivity is
conserved throughout the vertebrate evolutionary line <span class='cite'>[<a href='indexli5.html#Xgrillner_basal_2016'>130</a>]</span>. These nuclei are the striatum,
globus pallidus, subthalamic nucleus, and substantia nigra (Fig. <a href='#x7-170011'>2.1<!-- tex4ht:ref: fig:bg_anatomy  --></a>). In primates, the dorsal
part of the striatum is further subdivided into a head and a tail: the <span class='cmti-10x-x-109'>putamen </span>and <span class='cmti-10x-x-109'>caudate</span>,
and the globus pallidus is divided into an external and internal part (GPe and GPi,
respectively). The substantia nigra, finally, is divided into the <span class='cmti-10x-x-109'>pars reticulata </span>(SNr) and <span class='cmti-10x-x-109'>pars
</span><span class='cmti-10x-x-109'>compacta </span>(SNc).
</p>
   <figure class='figure'> 

                                                                                

                                                                                
<a id='x7-170011'></a>
                                                                                

                                                                                
<!-- l. 213 --><p class='noindent'><img alt='PIC' width='313' src='ch_background_literature/figs/BG_anatomy_wikicommons.jpg' height='313' />
</p>
<figcaption class='caption'><span class='id'>Figure 2.1:</span><span class='content'><span class='cmbx-10x-x-109'>Anatomy of the basal ganglia. </span>Subcortical nuclei of the basal ganglia and
thalamus by <span class='cite'>[<a href='indexli5.html#Xlim_how_2014'>205</a>]</span>, licensed under <a href='https://creativecommons.org/licenses/by/3.0/deed.en'>CC BY 3.0</a>. </span></figcaption><!-- tex4ht:label?: x7-170011  -->
                                                                                

                                                                                
   </figure>
   <figure class='figure'> 

                                                                                

                                                                                
<a id='x7-170022'></a>
                                                                                

                                                                                
<!-- l. 227 --><p class='noindent'><img alt='PIC' width='418' src='ch_background_literature/figs/BG_loops-cognitive.png' height='418' />
</p>
<figcaption class='caption'><span class='id'>Figure 2.2:</span><span class='content'><span class='cmbx-10x-x-109'>Functional subdivisions of the basal ganglia-thalamocortical loops.</span>
Reprinted from <span class='cite'>[<a href='indexli5.html#Xrodriguez-oroz_initial_2009'>307</a>]</span>, Copyright (2009), with permission from Elsevier. </span></figcaption><!-- tex4ht:label?: x7-170022  -->
                                                                                

                                                                                
   </figure>
   <h4 class='subsectionHead'><span class='titlemark'>2.3.1   </span> <a id='x7-180002.3.1'></a>Projection patterns and pathways</h4>
<!-- l. 242 --><p class='noindent'>As shown in Fig. <a href='#x7-170022'>2.2<!-- tex4ht:ref: fig:bg_loops-subdivisions  --></a>, the BG are organized in parallel loops corresponding to different
functional-cognitive domains. These basal ganglia-thalamocortical (BGTC) loops start from
distinct functional regions in the cortex and project topographically throughout the BG
starting in the striatum, the major input structure. The output structures of the BG are the
GPi and SNr, which target thalamic nuclei and areas of the brain stem. Through the
thalamus, the BG projects back to its input regions but it also has direct control over spinal
motor circuits via the brain stem. Although the topographic organization of the BG ensures a
high degree of segregation between loops <span class='cite'>[<a href='indexli5.html#Xalexander_parallel_1986'>14</a>]</span>, a sharp reduction in numbers of neurons and
axons from input to output also results in significant convergence of information along BG
pathways <span class='cite'>[<a href='indexli5.html#Xkandel_principles_2013'>173</a>]</span>.
</p>
   <figure class='figure'> 

                                                                                

                                                                                
<a id='x7-180013'></a>
                                                                                

                                                                                
<!-- l. 259 --><p class='noindent'><img alt='PIC' width='418' src='ch_background_literature/figs/Redgrave2007_BG_diagram_Scholarpedia.png' height='418' />
</p>
<figcaption class='caption'><span class='id'>Figure 2.3:</span><span class='content'><span class='cmbx-10x-x-109'>Major projections and pathways of the basal ganglia </span>by <span class='cite'>[<a href='indexli5.html#Xredgrave_basal_2007'>305</a>]</span>, licensed
under <a href='https://creativecommons.org/licenses/by-nc-sa/3.0/deed.en_US'>CC BY-NC-SA 3.0</a>. <span class='cmbx-10x-x-109'>A</span>: Traditional dual pathway model of the BG. <span class='cmbx-10x-x-109'>B</span>: Updated
connection patterns in the BG based on recent anatomical investigations. </span></figcaption><!-- tex4ht:label?: x7-180013  -->
                                                                                

                                                                                
   </figure>
<!-- l. 269 --><p class='indent'>   The major projections of the basal ganglia are shown in Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>. Most projection neurons
in the BG have an inhibitory effect on their targets (Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>, blue arrows), using the
neurotransmitter GABA. Moreover, because neurons in the output nuclei, the GPi and
SNr, are tonically active, the BG keeps its targets in the brain stem and thalamus
under constant inhibition. This tonic inhibition can be transiently lifted or increased
by a control system implemented by the other BG nuclei and driven by cortical
activity.
</p>
   <h5 class='likesubsubsectionHead'><a id='x7-190002.3.1'></a>Dual pathway model</h5>
<!-- l. 280 --><p class='noindent'>A classical and influential model, the <span class='cmti-10x-x-109'>dual pathway model </span><span class='cite'>[<a href='indexli5.html#Xalbin_functional_1989'>13</a>]</span>, posits a simple mechanism
where two pathways exert an opposing influence on the output nuclei (GPi/SNr): A <span class='cmti-10x-x-109'>direct
</span><span class='cmti-10x-x-109'>pathway</span>, originating in striatal medium spiny neurons (MSN) expressing D1-type dopamine
receptors (D1R), projects directly to the output nucleus (GPi) and disinhibits BG targets.
Another, <span class='cmti-10x-x-109'>indirect pathway </span>originating in D2 receptor (D2R) expressing MSN inhibits the GPe,
itself a source of tonic inhibition to GPi/SNr, and therefore has a net excitatory
effect on BG targets. The direct and indirect pathways have a push-pull influence on
GPi/SNr activity: they are also called the <span class='cmti-10x-x-109'>go </span>and <span class='cmti-10x-x-109'>no-go </span>pathways as their activation
facilitates and suppresses specific motor behaviors, respectively <span class='cite'>[<a href='indexli5.html#Xkravitz_regulation_2010'>188</a>]</span>, by regulating the
degree of inhibition over motor targets in cortex and brain stem circuits. This <span class='cmti-10x-x-109'>gating</span>
activity is resolved primarily in the striatum, where sensorimotor inputs from cortex
and contextual information about ongoing actions from thalamus are integrated
<span class='cite'>[<a href='indexli5.html#Xjin_shaping_2015'>167</a>, <a href='indexli5.html#Xjahanshahi_frontostriatosubthalamicpallidal_2015'>163</a>]</span>.
</p><!-- l. 297 --><p class='noindent'>
</p>
   <h5 class='likesubsubsectionHead'><a id='x7-200002.3.1'></a>Extended Dual Pathway Model</h5>
<!-- l. 298 --><p class='noindent'>While this dual pathway model has generally withstood experimental validation <span class='cite'>[<a href='indexli5.html#Xcalabresi_direct_2014'>54</a>, <a href='indexli5.html#Xfriend_working_2014'>112</a>]</span>,
subsequent anatomical and physiological studies have revealed a more complex organization of
BG circuitry (Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>.B) <span class='cite'>[<a href='indexli5.html#Xmallet_dichotomous_2012'>225</a>, <a href='indexli5.html#Xnambu_functional_2002'>260</a>, <a href='indexli5.html#Xcalabresi_direct_2014'>54</a>]</span>. Of particular importance is the <span class='cmti-10x-x-109'>hyperdirect pathway</span>,
projecting directly from the cortex to the STN, bypassing the striatum <span class='cite'>[<a href='indexli5.html#Xnambu_dual_1996'>259</a>]</span>. This projection
                                                                                

                                                                                
provides a low-latency pathway to the GPi/SNr that underlies fast inhibition of BG targets
and rapid termination of motor activities <span class='cite'>[<a href='indexli5.html#Xnambu_functional_2002'>260</a>]</span>. This pathway has received significant attention
in the context of PD because it is believed to play a key role in transmitting pathological
activity from the cortex to the STN, and in its suppression through activation by DBS
<span class='cite'>[<a href='indexli5.html#Xmackinnon_stimulation_2005'>218</a>, <a href='indexli5.html#Xli_resonant_2007'>203</a>, <a href='indexli5.html#Xgradinaru_optical_2009'>126</a>, <a href='indexli5.html#Xli_therapeutic_2012'>202</a>]</span>.
</p><!-- l. 312 --><p class='indent'>   Another set of projections crucial to the understanding of PD pathophysiology is SNc
innervation of the other BG nuclei, with the densest projections targeting the striatum
(Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>, green arrows). These projections use the neurotransmitter dopamine, acting as a
neuromodulator on its targets. There it regulates synaptic plasticity and neuronal excitability
through second messenger systems after binding G-protein coupled receptors of
the D1 and D2 families. During normal function, the SNc mediates reinforcement
learning in the BG by providing a phasic dopamine signal that codes for a reward
prediction error <span class='cite'>[<a href='indexli5.html#Xbayer_midbrain_2005'>25</a>]</span>. Its primary role is to strengthen neural pathways in the BG
that contributed to better-than-expected outcomes during everyday activities. This
reinforcing of pathways and associated behaviors is thought to underlie the acquisition
of habitual behaviors and motor sequences and operates by modulating neuronal
excitability and synaptic strengths in the BG, primarily between the cortex and
striatum.
</p><!-- l. 358 --><p class='noindent'>
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.3.2   </span> <a id='x7-210002.3.2'></a>Effects of dopamine depletion</h4>
<!-- l. 389 --><p class='noindent'>In PD, the dopaminergic cells of the SNc degenerate, resulting in a disruption to dopaminergic
innervation of the rest of the BG. This lack of dopamine leads to widespread structural and
functional changes throughout basal ganglia thalamo-cortical circuits, reflected in altered
neuronal activity patterns and the various motor and non-motor symptoms of PD. In this
section, the main neurobiological changes induced by DA depletion will be summarized
for each BG nucleus. In the following section, it will be discussed how distributed
changes in BG network pathophysiology are thought to arise as a result of these local
changes.
</p><!-- l. 401 --><p class='noindent'>
                                                                                

                                                                                
</p>
   <h5 class='likesubsubsectionHead'><a id='x7-220002.3.2'></a>STN</h5>
<!-- l. 404 --><p class='noindent'>Dopamine depletion induces changes in axonal innervation of the STN and in synaptic
transmission onto STN neurons (Table <a href='#x7-220011'>2.1<!-- tex4ht:ref: tab:dd-connectivy_stn-ctx  --></a>-<a href='#x7-220022'>2.2<!-- tex4ht:ref: tab:dd-connectivy_stn-gpe  --></a>). The dynamics of synaptic transmission are
altered presynaptically, through changes in the dynamics of synaptic release <span class='cite'>[<a href='indexli5.html#Xbaufreton_d2-like_2008'>23</a>]</span>, and
postsynaptically, by modulating the subunit composition of synaptic receptors <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span> and
altering dendritic branching and spine formation <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xwang_impaired_2018'>364</a>]</span>. Moreover, synaptic plasticity in the
STN is impaired, resulting in the inability of homeostatic mechanisms to balance excitatory
and inhibitory transmission to STN neurons <span class='cite'>[<a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>, <a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>. Strengthening of GPe synapses
<span class='cite'>[<a href='indexli5.html#Xfan_proliferation_2012'>99</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>, <a href='indexli5.html#Xbaufreton_d2-like_2008'>23</a>, <a href='indexli5.html#Xshen_dopamine_2005'>328</a>]</span> , in combination with faster AMPAR-mediated PSC <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>, increased coupling
of glutamergic synapses to intrinsic calcium ion channels <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xramanathan_d2-like_2008'>297</a>]</span>, and decreased conductance
of channels responsible for intrinsic pacemaking of STN neurons <span class='cite'>[<a href='indexli5.html#Xloucif_depolarisation_2008'>214</a>, <a href='indexli5.html#Xzhu_pharmacological_2002'>384</a>, <a href='indexli5.html#Xmciver_maladaptive_2019'>242</a>]</span> are thought
to lead to a situation where STN neurons are more susceptible to patterning by alternating
phases of rhythmic excitatory and inhibitory post-synaptic potentials (EPSP and IPSP,
respectively; <span class='cite'>[<a href='indexli5.html#Xbaufreton_enhancement_2005'>21</a>, <a href='indexli5.html#Xhallworth_globus_2005'>140</a>, <a href='indexli5.html#Xbevan_cellular_2006'>33</a>, <a href='indexli5.html#Xmallet_disrupted_2008'>224</a>, <a href='indexli5.html#Xmallet_dichotomous_2012'>225</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>]</span>).
                                                                                

                                                                                
</p><!-- l. 426 --><p class='indent'>   <a id='x7-220011'></a></p><figure class='float'>
                                                                                

                                                                                
<figcaption class='caption'><span class='id'>Table 2.1:</span><span class='content'><span class='cmbx-10x-x-109'>Effects of dopamine depletion on synaptic transmission in the STN.</span></span></figcaption><!-- tex4ht:label?: x7-220011  -->
<div class='tabular'>
 <table class='tabular' cellspacing='0' id='TBL-2' cellpadding='0'><colgroup id='TBL-2-1g'><col id='TBL-2-1' /><col id='TBL-2-2' /><col id='TBL-2-3' /><col id='TBL-2-4' /></colgroup><tr id='TBL-2-1-'><td class='td11' id='TBL-2-1-1' style='text-align:left;'> <!-- l. 431 --><p class='noindent'>Source   </p></td><td class='td11' id='TBL-2-1-2' style='text-align:left;'> <!-- l. 431 --><p class='noindent'>Feature                </p></td><td class='td11' id='TBL-2-1-3' style='text-align:left;'> <!-- l. 431 --><p class='noindent'>Effect dopamine depletion                        </p></td><td class='td11' id='TBL-2-1-4' style='text-align:left;'> <!-- l. 431 --><p class='noindent'>Experiment conditions                             </p></td>
</tr><tr id='TBL-2-2-'><td class='td11' id='TBL-2-2-1' style='text-align:left;'> <!-- l. 432 --><p class='noindent'>CTX      </p></td><td class='td11' id='TBL-2-2-2' style='text-align:left;'> <!-- l. 432 --><p class='noindent'>Synaptic currents   </p></td><td class='td11' id='TBL-2-2-3' style='text-align:left;'> <!-- l. 432 --><p class='noindent'>increased      AMPA-mediated      current;
  decreased NMDA-mediated current            </p></td><td class='td11' id='TBL-2-2-4' style='text-align:left;'> <!-- l. 432 --><p class='noindent'>6-OHDA  lesioned  rats,  brain  slices,  bath
  application of neurotransmitters <span class='cite'>[<a href='indexli5.html#Xshen_dopamine_2005'>328</a>]</span>         </p></td>
</tr><tr id='TBL-2-3-'><td class='td11' id='TBL-2-3-1' style='text-align:left;'> <!-- l. 433 --><p class='noindent'>CTX      </p></td><td class='td11' id='TBL-2-3-2' style='text-align:left;'> <!-- l. 433 --><p class='noindent'>Synaptic currents   </p></td><td class='td11' id='TBL-2-3-3' style='text-align:left;'> <!-- l. 433 --><p class='noindent'>amplitude  of  AMPAR-mediated  current
  reduced  by  factor  3;  restored  by  NMDA
  knockdown; no change in AMPAR:NMDAR
  ratio                                                    </p></td><td class='td11' id='TBL-2-3-4' style='text-align:left;'> <!-- l. 433 --><p class='noindent'>6-OHDA   lesioned   mice,   brain   slices,
  optogenetic stimulation <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>                      </p></td>
</tr><tr id='TBL-2-4-'><td class='td11' id='TBL-2-4-1' style='text-align:left;'> <!-- l. 434 --><p class='noindent'>CTX      </p></td><td class='td11' id='TBL-2-4-2' style='text-align:left;'> <!-- l. 434 --><p class='noindent'>Synaptic contacts   </p></td><td class='td11' id='TBL-2-4-3' style='text-align:left;'> <!-- l. 434 --><p class='noindent'>decrease   in   synaptic   contacts;   loss   of
  dendritic branching and spines                  </p></td><td class='td11' id='TBL-2-4-4' style='text-align:left;'> <!-- l. 434 --><p class='noindent'>6-OHDA  lesioned  mice,  brain  slices  <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>;
  6-OHDA lesioned rat <span class='cite'>[<a href='indexli5.html#Xwang_impaired_2018'>364</a>]</span>; MPTP lesioned
  monkeys <span class='cite'>[<a href='indexli5.html#Xmathai_reduced_2015'>231</a>]</span>                                        </p></td>
</tr><tr id='TBL-2-5-'><td class='td11' id='TBL-2-5-1' style='text-align:left;'> <!-- l. 435 --><p class='noindent'>CTX      </p></td><td class='td11' id='TBL-2-5-2' style='text-align:left;'> <!-- l. 435 --><p class='noindent'>AMPA     synapse
  subunit
  composition          </p></td><td class='td11' id='TBL-2-5-3' style='text-align:left;'> <!-- l. 435 --><p class='noindent'>reduced  Glu2A  subunit  expression;  faster
  AMPA-mediated PSC                             </p></td><td class='td11' id='TBL-2-5-4' style='text-align:left;'> <!-- l. 435 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>      </p></td>
</tr><tr id='TBL-2-6-'><td class='td11' id='TBL-2-6-1' style='text-align:left;'> <!-- l. 436 --><p class='noindent'>CTX      </p></td><td class='td11' id='TBL-2-6-2' style='text-align:left;'> <!-- l. 436 --><p class='noindent'>Synaptic plasticity  </p></td><td class='td11' id='TBL-2-6-3' style='text-align:left;'> <!-- l. 436 --><p class='noindent'>LTD of CTX-STN tranmission is impaired:
  no LTD when NMDAR activated; but no
  changes in STD                                      </p></td><td class='td11' id='TBL-2-6-4' style='text-align:left;'> <!-- l. 436 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>      </p></td>
</tr><tr id='TBL-2-7-'><td class='td11' id='TBL-2-7-1' style='text-align:left;'> <!-- l. 437 --><p class='noindent'>CTX,
  GPe       </p></td><td class='td11' id='TBL-2-7-2' style='text-align:left;'> <!-- l. 437 --><p class='noindent'>Synaptic plasticity  </p></td><td class='td11' id='TBL-2-7-3' style='text-align:left;'> <!-- l. 437 --><p class='noindent'>hLTP: Strength of CTX-STN and GPe-STN
  transmission normally balance each other;
  this  effect  is  contingent  on  NMDAR  and
  impaired by DD                                     </p></td><td class='td11' id='TBL-2-7-4' style='text-align:left;'> <!-- l. 437 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>]</span>  </p></td>
</tr><tr id='TBL-2-8-'><td class='td11' id='TBL-2-8-1' style='text-align:left;'> <!-- l. 438 --><p class='noindent'>CTX,
  GPe       </p></td><td class='td11' id='TBL-2-8-2' style='text-align:left;'> <!-- l. 438 --><p class='noindent'>Synaptic plasticity  </p></td><td class='td11' id='TBL-2-8-3' style='text-align:left;'> <!-- l. 438 --><p class='noindent'>in DD, GPe-STN transmission is maximally
  strengthened by impaired hLTP; the ratio
  of CTX-STN to GPe-STN transmission is
  reduced                                                </p></td><td class='td11' id='TBL-2-8-4' style='text-align:left;'> <!-- l. 438 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>]</span>  </p></td>

</tr></table>
</div>
                                                                                

                                                                                
   </figure>
                                                                                

                                                                                
<!-- l. 447 --><p class='indent'>   <a id='x7-220022'></a></p><figure class='float'>
                                                                                

                                                                                
<figcaption class='caption'><span class='id'>Table 2.2:</span><span class='content'><span class='cmbx-10x-x-109'>Effects of dopamine depletion on GPe-STN synaptic transmission.</span></span></figcaption><!-- tex4ht:label?: x7-220022  -->
<div class='tabular'>
 <table class='tabular' cellspacing='0' id='TBL-3' cellpadding='0'><colgroup id='TBL-3-1g'><col id='TBL-3-1' /><col id='TBL-3-2' /><col id='TBL-3-3' /><col id='TBL-3-4' /></colgroup><tr id='TBL-3-1-'><td class='td11' id='TBL-3-1-1' style='text-align:left;'> <!-- l. 451 --><p class='noindent'>Source   </p></td><td class='td11' id='TBL-3-1-2' style='text-align:left;'> <!-- l. 451 --><p class='noindent'>Feature                </p></td><td class='td11' id='TBL-3-1-3' style='text-align:left;'> <!-- l. 451 --><p class='noindent'>Effect dopamine depletion                        </p></td><td class='td11' id='TBL-3-1-4' style='text-align:left;'> <!-- l. 451 --><p class='noindent'>Experiment conditions                             </p></td>
</tr><tr id='TBL-3-2-'><td class='td11' id='TBL-3-2-1' style='text-align:left;'> <!-- l. 452 --><p class='noindent'>CTX,
  GPe       </p></td><td class='td11' id='TBL-3-2-2' style='text-align:left;'> <!-- l. 452 --><p class='noindent'>Synaptic plasticity  </p></td><td class='td11' id='TBL-3-2-3' style='text-align:left;'> <!-- l. 452 --><p class='noindent'>hLTP: Strength of CTX-STN and GPe-STN
  transmission normally balance each other;
  this  effect  is  contingent  on  NMDAR  and
  impaired by DD                                     </p></td><td class='td11' id='TBL-3-2-4' style='text-align:left;'> <!-- l. 452 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>]</span>  </p></td>
</tr><tr id='TBL-3-3-'><td class='td11' id='TBL-3-3-1' style='text-align:left;'> <!-- l. 453 --><p class='noindent'>CTX,
  GPe       </p></td><td class='td11' id='TBL-3-3-2' style='text-align:left;'> <!-- l. 453 --><p class='noindent'>Synaptic plasticity  </p></td><td class='td11' id='TBL-3-3-3' style='text-align:left;'> <!-- l. 453 --><p class='noindent'>in DD, GPe-STN transmission is maximally
  strengthened by impaired hLTP; the ratio
  of CTX-STN to GPe-STN transmission is
  reduced                                                </p></td><td class='td11' id='TBL-3-3-4' style='text-align:left;'> <!-- l. 453 --><p class='noindent'>6-OHDA lesioned mice, brain slices <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>, <a href='indexli5.html#Xchu_heterosynaptic_2015'>63</a>]</span>  </p></td>
</tr><tr id='TBL-3-4-'><td class='td11' id='TBL-3-4-1' style='text-align:left;'> <!-- l. 454 --><p class='noindent'>GPe       </p></td><td class='td11' id='TBL-3-4-2' style='text-align:left;'> <!-- l. 454 --><p class='noindent'>Synaptic currents   </p></td><td class='td11' id='TBL-3-4-3' style='text-align:left;'> <!-- l. 454 --><p class='noindent'>Increased   release   probability,   frequency,
  decay kinetics of GPe-STN synapses.          </p></td><td class='td11' id='TBL-3-4-4' style='text-align:left;'> <!-- l. 454 --><p class='noindent'>6-OHDA lesioned rats, brain slices <span class='cite'>[<a href='indexli5.html#Xfan_proliferation_2012'>99</a>, <a href='indexli5.html#Xbaufreton_d2-like_2008'>23</a>,
   <a href='indexli5.html#Xshen_presynaptic_2000'>327</a>]</span>                                                   </p></td>
</tr><tr id='TBL-3-5-'><td class='td11' id='TBL-3-5-1' style='text-align:left;'> <!-- l. 455 --><p class='noindent'>GPe       </p></td><td class='td11' id='TBL-3-5-2' style='text-align:left;'> <!-- l. 455 --><p class='noindent'>Synaptic contacts   </p></td><td class='td11' id='TBL-3-5-3' style='text-align:left;'> <!-- l. 455 --><p class='noindent'>Increase   in   the   number   of   GPE-STN
  synapses                                               </p></td><td class='td11' id='TBL-3-5-4' style='text-align:left;'> <!-- l. 455 --><p class='noindent'>6-OHDA lesioned rats, brain slices <span class='cite'>[<a href='indexli5.html#Xfan_proliferation_2012'>99</a>, <a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>  </p></td>
</tr><tr id='TBL-3-6-'><td class='td11' id='TBL-3-6-1' style='text-align:left;'> <!-- l. 456 --><p class='noindent'>GPe       </p></td><td class='td11' id='TBL-3-6-2' style='text-align:left;'> <!-- l. 456 --><p class='noindent'>Synaptic currents   </p></td><td class='td11' id='TBL-3-6-3' style='text-align:left;'> <!-- l. 456 --><p class='noindent'>increased  GABAA  and  GABAB-mediated
  currents                                                </p></td><td class='td11' id='TBL-3-6-4' style='text-align:left;'> <!-- l. 456 --><p class='noindent'>6-OHDA lesioned rats, brain slices <span class='cite'>[<a href='indexli5.html#Xshen_dopamine_2005'>328</a>]</span>      </p></td>

</tr></table>
</div>
                                                                                

                                                                                
   </figure>
                                                                                

                                                                                
<!-- l. 466 --><p class='indent'>   <a id='x7-220033'></a></p><figure class='float'>
                                                                                

                                                                                
<figcaption class='caption'><span class='id'>Table 2.3:</span><span class='content'><span class='cmbx-10x-x-109'>Effects of dopamine depletion on intrinsic STN neuron properties.</span></span></figcaption><!-- tex4ht:label?: x7-220033  -->
                                                                                

                                                                                
<div class='adjustbox' id='adjustbox-1'> <!-- tex4ht:inline --><div class='tabular'>
 <table class='tabular' cellspacing='0' id='TBL-4' cellpadding='0'><colgroup id='TBL-4-1g'><col id='TBL-4-1' /><col id='TBL-4-2' /><col id='TBL-4-3' /><col id='TBL-4-4' /><col id='TBL-4-5' /></colgroup><tr id='TBL-4-1-'><td class='td11' id='TBL-4-1-1' style='text-align:left;'> <!-- l. 471 --><p class='noindent'>Feature        </p></td><td class='td11' id='TBL-4-1-2' style='text-align:left;'> <!-- l. 471 --><p class='noindent'>Causes         </p></td><td class='td11' id='TBL-4-1-3' style='text-align:left;'> <!-- l. 471 --><p class='noindent'>DD-induced changes       </p></td><td class='td11' id='TBL-4-1-4' style='text-align:left;'> <!-- l. 471 --><p class='noindent'>Physiological effects        </p></td><td class='td11' id='TBL-4-1-5' style='text-align:left;'> <!-- l. 471 --><p class='noindent'>Experimental setting                       </p></td>
</tr><tr id='TBL-4-2-'><td class='td11' id='TBL-4-2-1' style='text-align:left;'> <!-- l. 472 --><p class='noindent'>AMPA
  synapse
  subunit
  composition   </p></td><td class='td11' id='TBL-4-2-2' style='text-align:left;'> <!-- l. 472 --><p class='noindent'>CTX           </p></td><td class='td11' id='TBL-4-2-3' style='text-align:left;'> <!-- l. 472 --><p class='noindent'>reduced  Glu2A  subunit
  expression                     </p></td><td class='td11' id='TBL-4-2-4' style='text-align:left;'> <!-- l. 472 --><p class='noindent'>increased    permeability
  to Ca2+                       </p></td><td class='td11' id='TBL-4-2-5' style='text-align:left;'> <!-- l. 472 --><p class='noindent'>6-OHDA  lesioned  mice,  brain  slices
  <span class='cite'>[<a href='indexli5.html#Xchu_loss_2017'>64</a>]</span>                                              </p></td>
</tr><tr id='TBL-4-3-'><td class='td11' id='TBL-4-3-1' style='text-align:left;'> <!-- l. 473 --><p class='noindent'>ion  channel
  expression     </p></td><td class='td11' id='TBL-4-3-2' style='text-align:left;'> <!-- l. 473 --><p class='noindent'>reduced
  D2R
  activation     </p></td><td class='td11' id='TBL-4-3-3' style='text-align:left;'> <!-- l. 473 --><p class='noindent'>increased             SKCa
  conductance      through
  increased
  Cav2.2   activation   and
  Ca2+ coupling.              </p></td><td class='td11' id='TBL-4-3-4' style='text-align:left;'> <!-- l. 473 --><p class='noindent'>reduced        excitability
  and bursting, less linear
  response.                      </p></td><td class='td11' id='TBL-4-3-5' style='text-align:left;'> <!-- l. 473 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xramanathan_d2-like_2008'>297</a>]</span>                                            </p></td>
</tr><tr id='TBL-4-4-'><td class='td11' id='TBL-4-4-1' style='text-align:left;'> <!-- l. 474 --><p class='noindent'>ion  channel
  expression     </p></td><td class='td11' id='TBL-4-4-2' style='text-align:left;'> <!-- l. 474 --><p class='noindent'>reduced
  D1R
  activation     </p></td><td class='td11' id='TBL-4-4-3' style='text-align:left;'> <!-- l. 474 --><p class='noindent'>reduced  conductance  of
  depolarizing          HCN
  channel                        </p></td><td class='td11' id='TBL-4-4-4' style='text-align:left;'> <!-- l. 474 --><p class='noindent'>reduced
  recovery from inhibition;
  increased de-inactivation
  of
  CaT channels; increased
  rebound bursting           </p></td><td class='td11' id='TBL-4-4-5' style='text-align:left;'> <!-- l. 474 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xloucif_depolarisation_2008'>214</a>, <a href='indexli5.html#Xyang_d2_2016'>375</a>, <a href='indexli5.html#Xbaufreton_d2-like_2008'>23</a>, <a href='indexli5.html#Xzhu_pharmacological_2002'>384</a>, <a href='indexli5.html#Xshen_synaptic_2003'>329</a>, <a href='indexli5.html#Xatherton_selective_2010'>18</a>, <a href='indexli5.html#Xbaufreton_d5_2003'>24</a>,
   <a href='indexli5.html#Xfloran_dopamine_2004'>107</a>]</span>                                           </p></td>
</tr><tr id='TBL-4-5-'><td class='td11' id='TBL-4-5-1' style='text-align:left;'> <!-- l. 475 --><p class='noindent'>ion  channel
  expression     </p></td><td class='td11' id='TBL-4-5-2' style='text-align:left;'> <!-- l. 475 --><p class='noindent'>reduced
  D5R
  activation     </p></td><td class='td11' id='TBL-4-5-3' style='text-align:left;'> <!-- l. 475 --><p class='noindent'>reduced   Cav1   channel
  conductance                  </p></td><td class='td11' id='TBL-4-5-4' style='text-align:left;'> <!-- l. 475 --><p class='noindent'>reduced excitability and
  bursting                       </p></td><td class='td11' id='TBL-4-5-5' style='text-align:left;'> <!-- l. 475 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xbaufreton_d5_2003'>24</a>, <a href='indexli5.html#Xchetrit_inhibiting_2013'>60</a>]</span>                                        </p></td>
</tr><tr id='TBL-4-6-'><td class='td11' id='TBL-4-6-1' style='text-align:left;'> <!-- l. 477 --><p class='noindent'>ion  channel
  expression     </p></td><td class='td11' id='TBL-4-6-2' style='text-align:left;'> <!-- l. 477 --><p class='noindent'>D1R/D5R
  mediated
  activation of
  cAMP/PKA
  pathway       </p></td><td class='td11' id='TBL-4-6-3' style='text-align:left;'> <!-- l. 477 --><p class='noindent'>reduced   activation   of
  cyclic-nucleotide    gated
  (CNG)        non-specific
  cation channel               </p></td><td class='td11' id='TBL-4-6-4' style='text-align:left;'> <!-- l. 477 --><p class='noindent'>reduced excitability and
  spontaneous activity       </p></td><td class='td11' id='TBL-4-6-5' style='text-align:left;'> <!-- l. 477 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xloucif_depolarisation_2008'>214</a>]</span>                                            </p></td>
</tr><tr id='TBL-4-7-'><td class='td11' id='TBL-4-7-1' style='text-align:left;'> <!-- l. 479 --><p class='noindent'>ion  channel
  activation      </p></td><td class='td11' id='TBL-4-7-2' style='text-align:left;'> <!-- l. 479 --><p class='noindent'>           </p></td><td class='td11' id='TBL-4-7-3' style='text-align:left;'> <!-- l. 479 --><p class='noindent'>increased conductance of
  voltage-independent K+
  channels                       </p></td><td class='td11' id='TBL-4-7-4' style='text-align:left;'> <!-- l. 479 --><p class='noindent'>reduced excitability and
  spontaneous activity       </p></td><td class='td11' id='TBL-4-7-5' style='text-align:left;'> <!-- l. 479 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xzhu_pharmacological_2002'>384</a>]</span>                                            </p></td>
</tr><tr id='TBL-4-8-'><td class='td11' id='TBL-4-8-1' style='text-align:left;'> <!-- l. 480 --><p class='noindent'>ion  channel
  activation      </p></td><td class='td11' id='TBL-4-8-2' style='text-align:left;'> <!-- l. 480 --><p class='noindent'>increased
  hyperpolarization
  of        STN
  neurons        </p></td><td class='td11' id='TBL-4-8-3' style='text-align:left;'> <!-- l. 480 --><p class='noindent'>voltage-dependent
  de-inactivation
  of  CaT,  CaL  channels,
  NMDAR-dependent
  activation     of     CAN
  channels                       </p></td><td class='td11' id='TBL-4-8-4' style='text-align:left;'> <!-- l. 480 --><p class='noindent'>increased bursting          </p></td><td class='td11' id='TBL-4-8-5' style='text-align:left;'> <!-- l. 480 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xbeurrier_subthalamic_1999'>30</a>, <a href='indexli5.html#Xzhu_nmda_2005'>383</a>]</span>                                       </p></td>
</tr><tr id='TBL-4-9-'><td class='td11' id='TBL-4-9-1' style='text-align:left;'> <!-- l. 481 --><p class='noindent'>ion  channel
  activation      </p></td><td class='td11' id='TBL-4-9-2' style='text-align:left;'> <!-- l. 481 --><p class='noindent'>disinhibition
  by GPe        </p></td><td class='td11' id='TBL-4-9-3' style='text-align:left;'> <!-- l. 481 --><p class='noindent'>homeostatic
  upregulation             of
  <!-- l. 481 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'><msub><mrow><mi>K</mi></mrow><mrow><mi mathvariant='italic'>ATP</mi> </mrow></msub></math>
  channel    mediated    by
  NMDAR activation        </p></td><td class='td11' id='TBL-4-9-4' style='text-align:left;'> <!-- l. 481 --><p class='noindent'>reduced      autonomous
  activity                        </p></td><td class='td11' id='TBL-4-9-5' style='text-align:left;'> <!-- l. 481 --><p class='noindent'><span class='cite'>[<a href='indexli5.html#Xmciver_maladaptive_2019'>242</a>]</span>                                            </p></td>
</tr></table>
                                                                                

                                                                                
</div> </div>
                                                                                

                                                                                
   </figure>
   <h5 class='likesubsubsectionHead'><a id='x7-230002.3.2'></a>GPe</h5>
<!-- l. 496 --><p class='noindent'>In the GPe, dopamine depletion leads to increased GABAergic transmission due to
strengthening of GPe-GPe collaterals <span class='cite'>[<a href='indexli5.html#Xmiguelez_altered_2012'>248</a>, <a href='indexli5.html#Xwatanabe_presynaptic_2009'>366</a>]</span>, and increased transmission through the
striatal indirect pathway because of elevated iMSN activity <span class='cite'>[<a href='indexli5.html#Xmallet_cortical_2006'>222</a>, <a href='indexli5.html#Xkita_cortical_2011'>181</a>]</span>, an increase in the
number of functionally active MSN-GPe synapses <span class='cite'>[<a href='indexli5.html#Xingham_plasticity_1997'>162</a>]</span>, and an increase in their initial
release probability <span class='cite'>[<a href='indexli5.html#Xshin_dopamine_2003'>333</a>, <a href='indexli5.html#Xcooper_dopamine_2001'>66</a>]</span>. Glutamergic transmission from the STN is strengthened
<span class='cite'>[<a href='indexli5.html#Xmatsui_activation_2003'>232</a>, <a href='indexli5.html#Xhernandez_control_2006'>151</a>, <a href='indexli5.html#Xjohnson_gaba-_1997'>169</a>, <a href='indexli5.html#Xkita_globus_2007'>183</a>]</span> and intrinsic cellular properties of GPe neurons are also affected.
Importantly, the expression of HCN channels is downregulated after DD <span class='cite'>[<a href='indexli5.html#Xchan_hcn_2011'>56</a>]</span>, resulting in
decreased autonomous pacemaking and a decreased ability of IPSP to reset GPe pacemaking
<span class='cite'>[<a href='indexli5.html#Xchan_hcn2_2004'>55</a>]</span>.
</p><!-- l. 513 --><p class='noindent'>
</p>
   <h5 class='likesubsubsectionHead'><a id='x7-240002.3.2'></a>Striatum</h5>
<!-- l. 516 --><p class='noindent'>The striatum is one of the primary sites of dopaminergic innervation in the BG,
where phasic dopamine release modulates synaptic plasticity and plays a role in
learning motor behaviors. The main role of dopamine is to strengthen cortico-striatal
synapses of the direct pathway, facilitating interruption of the tonic inhibition of motor
targets by GPi/SNr, and to weaken those in the indirect pathway (both pro-kinetic
changes). The loss of dopamine reverses this effect, weakening the direct pathway and
strengthening the indirect pathway, both anti-kinetic changes (Table <a href='#x7-240014'>2.4<!-- tex4ht:ref: tab:dd-striatum-phys  --></a>). This results in
homeostatic adaptations at multiple levels <span class='cite'>[<a href='indexli5.html#Xzhai_striatal_2018'>380</a>]</span>. In the indirect pathway, for example,
the strengthening of existing CTX-iMSN synapses leads to a compensatory loss of
dendritic arborization and pruning of spines <span class='cite'>[<a href='indexli5.html#Xfieblinger_cell_2014'>104</a>, <a href='indexli5.html#Xsuarez_l-dopa_2014'>340</a>, <a href='indexli5.html#Xday_selective_2006'>75</a>]</span>, but an increase in iMSN
intrinsic excitability <span class='cite'>[<a href='indexli5.html#Xhernandez-lopez_d2_2000'>152</a>, <a href='indexli5.html#Xday_selective_2006'>75</a>]</span>. Moreover, striatal FSI shift their projections from dMSN
to iMSN <span class='cite'>[<a href='indexli5.html#Xgittis_rapid_2011'>122</a>]</span>, and the GPe-MSN backprojection mediated by GPe arkypallidal
neurons is strengthened <span class='cite'>[<a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>]</span>, leading to increased inhibition of iMSN of the indirect
pathway.
                                                                                

                                                                                
</p><!-- l. 536 --><p class='indent'>   <a id='x7-240014'></a></p><figure class='float'>
                                                                                

                                                                                
<figcaption class='caption'><span class='id'>Table 2.4:</span><span class='content'><span class='cmbx-10x-x-109'>Effects of dopamine depletion on Striatum neurophysiology.</span></span></figcaption><!-- tex4ht:label?: x7-240014  -->
<div class='adjustbox' id='adjustbox-2'> <!-- tex4ht:inline --><div class='tabular'>
 <table class='tabular' cellspacing='0' id='TBL-5' cellpadding='0'><colgroup id='TBL-5-1g'><col id='TBL-5-1' /><col id='TBL-5-2' /><col id='TBL-5-3' /><col id='TBL-5-4' /></colgroup><tr id='TBL-5-1-'><td class='td11' id='TBL-5-1-1' style='text-align:left;'> <!-- l. 542 --><p class='noindent'>Population
  /
  Projection </p> </td> <td class='td11' id='TBL-5-1-2' style='text-align:left;'> <!-- l. 542 --><p class='noindent'>Feature                </p></td><td class='td11' id='TBL-5-1-3' style='text-align:left;'> <!-- l. 542 --><p class='noindent'>Effect dopamine depletion                        </p></td><td class='td11' id='TBL-5-1-4' style='text-align:left;'> <!-- l. 542 --><p class='noindent'>Experiment conditions                             </p></td>

</tr><tr id='TBL-5-2-'><td class='td11' id='TBL-5-2-1' style='text-align:left;'> <!-- l. 544 --><p class='noindent'>iMSN     </p></td><td class='td11' id='TBL-5-2-2' style='text-align:left;'> <!-- l. 544 --><p class='noindent'>spontaneous
  activity                </p></td><td class='td11' id='TBL-5-2-3' style='text-align:left;'> <!-- l. 544 --><p class='noindent'>firing rates increased                               </p></td><td class='td11' id='TBL-5-2-4' style='text-align:left;'> <!-- l. 544 --><p class='noindent'>6-OHDA lesioned rats, mice, monkeys <span class='cite'>[<a href='indexli5.html#Xmallet_cortical_2006'>222</a>,
   <a href='indexli5.html#Xkita_cortical_2011'>181</a>, <a href='indexli5.html#Xday_selective_2006'>75</a>, <a href='indexli5.html#Xfieblinger_cell_2014'>104</a>]</span>                                       </p></td>
</tr><tr id='TBL-5-3-'><td class='td11' id='TBL-5-3-1' style='text-align:left;'> <!-- l. 546 --><p class='noindent'>Ctx-iMSN </p> </td> <td class='td11' id='TBL-5-3-2' style='text-align:left;'> <!-- l. 546 --><p class='noindent'>synaptic contacts   </p></td><td class='td11' id='TBL-5-3-3' style='text-align:left;'> <!-- l. 546 --><p class='noindent'>loss   of   glutamergic   synapses,   dendritic
  spines, arborization                                 </p></td><td class='td11' id='TBL-5-3-4' style='text-align:left;'> <!-- l. 546 --><p class='noindent'>6-OHDA lesioned rats, mice, monkeys <span class='cite'>[<a href='indexli5.html#Xday_selective_2006'>75</a>,
   <a href='indexli5.html#Xfieblinger_cell_2014'>104</a>, <a href='indexli5.html#Xsuarez_l-dopa_2014'>340</a>]</span>                                             </p></td>
</tr><tr id='TBL-5-4-'><td class='td11' id='TBL-5-4-1' style='text-align:left;'> <!-- l. 548 --><p class='noindent'>MSN-MSN </p> </td> <td class='td11' id='TBL-5-4-2' style='text-align:left;'> <!-- l. 548 --><p class='noindent'>synaptic  strength,
  contacts               </p></td><td class='td11' id='TBL-5-4-3' style='text-align:left;'> <!-- l. 548 --><p class='noindent'>reduced    connection    probability,    iPSC
  amplitude                                             </p></td><td class='td11' id='TBL-5-4-4' style='text-align:left;'> <!-- l. 548 --><p class='noindent'>6-OHDA lesioned mice <span class='cite'>[<a href='indexli5.html#Xtaverna_recurrent_2008'>348</a>]</span>                     </p></td>
</tr><tr id='TBL-5-5-'><td class='td11' id='TBL-5-5-1' style='text-align:left;'> <!-- l. 550 --><p class='noindent'>FSI-iMSN </p> </td> <td class='td11' id='TBL-5-5-2' style='text-align:left;'> <!-- l. 550 --><p class='noindent'>synaptic strength   </p></td><td class='td11' id='TBL-5-5-3' style='text-align:left;'> <!-- l. 550 --><p class='noindent'>increased connection probability                </p></td><td class='td11' id='TBL-5-5-4' style='text-align:left;'> <!-- l. 550 --><p class='noindent'>6-OHDA lesioned mice <span class='cite'>[<a href='indexli5.html#Xgittis_rapid_2011'>122</a>]</span>                     </p></td>
</tr><tr id='TBL-5-6-'><td class='td11' id='TBL-5-6-1' style='text-align:left;'> <!-- l. 552 --><p class='noindent'>GPe-iMSN </p> </td> <td class='td11' id='TBL-5-6-2' style='text-align:left;'> <!-- l. 552 --><p class='noindent'>synaptic  strength,
  contacts               </p></td><td class='td11' id='TBL-5-6-3' style='text-align:left;'> <!-- l. 552 --><p class='noindent'>increased connection probability, IPSC       </p></td><td class='td11' id='TBL-5-6-4' style='text-align:left;'> <!-- l. 552 --><p class='noindent'>6-OHDA lesioned mice <span class='cite'>[<a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>]</span>                       </p></td>
</tr></table>
</div> </div>
                                                                                

                                                                                
   </figure>
   <h4 class='subsectionHead'><span class='titlemark'>2.3.3   </span> <a id='x7-250002.3.3'></a>Pathological firing patterns and oscillations</h4>
<!-- l. 593 --><p class='noindent'>In the traditional understanding of BG pathophysiology in Parkinson’s disease, the
synaptic plasticity changes induced by dopamine loss (discussed in Section <a href='#x7-210002.3.2'>2.3.2<!-- tex4ht:ref: sec:ch2-dd-effects  --></a>) result
in an imbalance in activity in the direct and indirect pathways of the BG. Under
this hypothesis (<span class='cmti-10x-x-109'>rate model </span>of PD), this imbalance leads to hyperactivity of the
BG output nuclei in the GPi/SNr resulting in the hypokinetic motor symptoms
of PD <span class='cite'>[<a href='indexli5.html#Xdelong_primate_1990'>80</a>, <a href='indexli5.html#Xalbin_functional_1989'>13</a>]</span>. However, while changes in neuronal firing rates in the striatum,
GPe, and STN largely agree with this hypothesis <span class='cite'>[<a href='indexli5.html#Xgalvan_alterations_2015'>117</a>]</span>, later studies showed that
alterations in firing patterns rather than rates may have a stronger relation to the
motor symptoms of PD <span class='cite'>[<a href='indexli5.html#Xlevy_high-frequency_2000'>201</a>, <a href='indexli5.html#Xbrown_dopamine_2001'>44</a>, <a href='indexli5.html#Xbrown_abnormal_2007'>43</a>, <a href='indexli5.html#Xsanders_parkinsonism-related_2013'>314</a>, <a href='indexli5.html#Xsharott_activity_2014'>323</a>, <a href='indexli5.html#Xpan_neuronal_2016'>273</a>, <a href='indexli5.html#Xkita_cortical_2011'>181</a>]</span>. In particular, dopamine
depletion has been associated with a loss of specificity in neuronal responses <span class='cite'>[<a href='indexli5.html#Xbronfeld_loss_2011'>40</a>]</span>,
characterized by increased synchrony in neuronal activity within and between nuclei
<span class='cite'>[<a href='indexli5.html#Xbergman_physiological_1998'>29</a>, <a href='indexli5.html#Xdostrovsky_oscillatory_2004'>88</a>, <a href='indexli5.html#Xbronte-stewart_stn_2009'>42</a>, <a href='indexli5.html#Xhammond_pathological_2007'>142</a>, <a href='indexli5.html#Xlevy_high-frequency_2000'>201</a>, <a href='indexli5.html#Xheimer_dopamine_2002'>148</a>]</span> and exaggerated oscillatory activity throughout the BG
<span class='cite'>[<a href='indexli5.html#Xsharott_dopamine_2005'>325</a>, <a href='indexli5.html#Xmallet_disrupted_2008'>224</a>, <a href='indexli5.html#Xkuhn_high-frequency_2008'>189</a>, <a href='indexli5.html#Xbrown_dopamine_2001'>44</a>, <a href='indexli5.html#Xbrown_abnormal_2007'>43</a>]</span>.
</p><!-- l. 609 --><p class='indent'>   During normal brain function, oscillatory synchronization is believed to play a key role in
communication between brain regions by temporally coordinating firing patterns <span class='cite'>[<a href='indexli5.html#Xengel_dynamic_2001'>94</a>, <a href='indexli5.html#Xwomelsdorf_modulation_2007'>373</a>]</span>. In
the BG for instance, transient beta-band synchronization occurs in healthy patients and
animals <span class='cite'>[<a href='indexli5.html#Xpfurtscheller_post-movement_1996'>282</a>, <a href='indexli5.html#Xleventhal_basal_2012'>200</a>, <a href='indexli5.html#Xwessel_stop-related_2016'>370</a>, <a href='indexli5.html#Xlipski_dynamics_2017'>208</a>, <a href='indexli5.html#Xkhanna_beta_2017'>177</a>]</span> and is thought to underlie the suppression of competing
motor plans (global motor suppression) in favor of the active motor program (status
quo) during sensory cue utilization <span class='cite'>[<a href='indexli5.html#Xgilbertson_existing_2005'>118</a>, <a href='indexli5.html#Xleventhal_basal_2012'>200</a>, <a href='indexli5.html#Xfeingold_bursts_2015'>102</a>]</span>. Conversely, phasic movement is
correlated with a reduction in cortico-muscular coherence in the beta-band <span class='cite'>[<a href='indexli5.html#Xbrown_cortical_1998'>45</a>]</span>.
Hence beta band power in the BGTC and motor circuits has been interpreted as a
global stop signal that delays movement execution while sensory information is still
being processed in preparation for the activation of a motor program (buying time
hypothesis, <span class='cite'>[<a href='indexli5.html#Xfrank_hold_2006'>109</a>]</span>). However in Parkinson’s disease, exaggerated synchronization
occurring in the form of prolonged and more frequent beta bursts are linked to the
disruption of normal sensorimotor processing and correlate with motor impairment
<span class='cite'>[<a href='indexli5.html#Xtinkhauser_modulatory_2017'>353</a>, <a href='indexli5.html#Xtinkhauser_beta_2017'>354</a>]</span>.
</p><!-- l. 634 --><p class='indent'>   Indeed, beta-band (13-30 Hz) oscillations in the BG are consistently strengthened with
dopamine depletion, both in individuals with PD and in parkinsonian animal models
                                                                                

                                                                                
<span class='cite'>[<a href='indexli5.html#Xsharott_dopamine_2005'>325</a>, <a href='indexli5.html#Xmallet_disrupted_2008'>224</a>, <a href='indexli5.html#Xkuhn_high-frequency_2008'>189</a>]</span>, and are reduced by deep brain stimulation and pharmacological interventions
that alleviate parkinsonian motor symptoms <span class='cite'>[<a href='indexli5.html#Xkuhn_reduction_2006'>190</a>, <a href='indexli5.html#Xweinberger_beta_2006'>369</a>, <a href='indexli5.html#Xeusebio_deep_2011'>97</a>, <a href='indexli5.html#Xray_local_2008'>303</a>]</span>. The magnitude of
subthalamic nucleus local field potential beta oscillations is also correlated with
the severity and degree of improvement of bradykinetic/akinetic motor symptoms
and rigidity <span class='cite'>[<a href='indexli5.html#Xkuhn_reduction_2006'>190</a>, <a href='indexli5.html#Xbronte-stewart_stn_2009'>42</a>, <a href='indexli5.html#Xneumann_subthalamic_2016'>262</a>]</span>. Although beta-band oscillations may not be causal to
bradykinetic/akinetic symptoms <span class='cite'>[<a href='indexli5.html#Xleblois_late_2007'>197</a>, <a href='indexli5.html#Xsyed_oscillatory_2012'>342</a>, <a href='indexli5.html#Xdevergnas_relationship_2014'>85</a>, <a href='indexli5.html#Xpan_neuronal_2016'>273</a>]</span>, they offer potential as a biomarker for
symptom severity and the underlying network pathophysiology in advanced Parkinson’s
Disease <span class='cite'>[<a href='indexli5.html#Xrosin_closed-loop_2011'>311</a>, <a href='indexli5.html#Xlittle_adaptive_2013'>210</a>]</span>. Other studies have found that sub-beta-band oscillations
(<!-- l. 650 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'> <mo class='MathClass-rel'>&lt;</mo></math> 13
Hz) in the LFP are correlated with bradykinetic-akinetic and axial symptoms of PD <span class='cite'>[<a href='indexli5.html#Xsharott_activity_2014'>323</a>, <a href='indexli5.html#Xdevergnas_relationship_2014'>85</a>]</span>.
This frequency band overlaps with the frequency range of Parkinsonian tremor (4-7 Hz,
<span class='cite'>[<a href='indexli5.html#Xkoller_tremors_1989'>186</a>, <a href='indexli5.html#Xmoustafa_motor_2016'>258</a>]</span>). Tremor-related activity has been observed in the STN in single cell and multi-unit
spiking activity <span class='cite'>[<a href='indexli5.html#Xmagarinos-ascone_subthalamic_2000'>219</a>, <a href='indexli5.html#Xamtage_tremor-correlated_2008'>15</a>]</span>, and in local field potentials <span class='cite'>[<a href='indexli5.html#Xreck_characterisation_2009'>304</a>, <a href='indexli5.html#Xtass_causal_2010'>344</a>]</span>. Finaly, gamma band
(<!-- l. 666 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'> <mo class='MathClass-rel'>&gt;</mo></math> 30
Hz) oscillations in the BG and thalamic receiving areas of the BG are reported as pro-kinetic
in PD patients and correlated positively with movement and DA administration in several
studies <span class='cite'>[<a href='indexli5.html#Xkempf_gamma_2009'>176</a>, <a href='indexli5.html#Xkammermeier_effects_2016'>172</a>, <a href='indexli5.html#Xdevergnas_relationship_2014'>85</a>, <a href='indexli5.html#Xbrown_dopamine_2001'>44</a>]</span>.
</p><!-- l. 673 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-260002.3.3'></a>Mechanisms of oscillations</h5>
<!-- l. 682 --><p class='noindent'>The origin of exaggerated beta-band oscillations in the dopamine-depleted BGTC network,
however, remains unclear. The most prominent hypotheses emphasize the importance of
dopamine-modulated strengthening of particular feedback loops within the BGTC network.
Computational models have provided a valuable tool with which to explore various hypotheses
regarding the mechanisms by which oscillatory activity with the network is generated.
Different models have placed the origin of beta and sub-beta-band oscillations in the
STN-GPe network <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>, <a href='indexli5.html#Xgillies_neuroinformatics_2007'>121</a>, <a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xpavlides_improved_2012'>279</a>]</span>, in cortical and thalamo-cortical circuits
<span class='cite'>[<a href='indexli5.html#Xsherman_neural_2016'>330</a>, <a href='indexli5.html#Xreis_thalamocortical_2019'>306</a>, <a href='indexli5.html#Xpavlides_computational_2015'>278</a>, <a href='indexli5.html#Xliu_neural_2017'>213</a>]</span>, in striatal or pallidostriatal circuits <span class='cite'>[<a href='indexli5.html#Xmccarthy_striatal_2011'>235</a>, <a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>, <a href='indexli5.html#Xdamodaran_desynchronization_2015'>70</a>]</span>, or in the full BGTC
loop <span class='cite'>[<a href='indexli5.html#Xpavlides_computational_2015'>278</a>, <a href='indexli5.html#Xkumaravelu_biophysical_2016'>193</a>, <a href='indexli5.html#Xleblois_competition_2006'>196</a>, <a href='indexli5.html#Xkang_interaction_2013'>174</a>]</span>. These models show that under many conditions the network is
prone to oscillate, through intrinsic pacemaking or susceptibility to an extrinsic
rhythm.
</p><!-- l. 700 --><p class='indent'>   The reciprocally connected subthalamo-pallidal (STN-GPe) network is a key site in the
                                                                                

                                                                                
basal ganglia in which beta-band oscillations are manifest in Parkinson’s disease <span class='cite'>[<a href='indexli5.html#Xmallet_parkinsonian_2008'>223</a>, <a href='indexli5.html#Xmallet_disrupted_2008'>224</a>]</span>.
This network was an early focus of modelling studies due to its reciprocally connected
structure and ability to generate low frequency oscillations in tissue cultures <span class='cite'>[<a href='indexli5.html#Xplenz_basal_1999'>287</a>]</span>. Models of
the STN-GPe as a pacemaker initially focused on the generation of low frequency oscillations
within the frequency range of parkinsonian tremor <span class='cite'>[<a href='indexli5.html#Xgillies_subthalamic-pallidal_2002'>119</a>, <a href='indexli5.html#Xterman_activity_2002'>349</a>]</span>, with focus shifting to the
beta-band with increasing evidence of a link between beta activity and parkinsonian motor
symptoms <span class='cite'>[<a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xpavlides_improved_2012'>279</a>]</span>.
</p><!-- l. 712 --><p class='indent'>   More recent experimental evidence suggests that, rather than the STN-GPe network
operating in a pacemaking mode, patterning by cortex may play a critical role in
the generation of pathological beta-band oscillations in Parkinson’s disease. This is
supported by observations of high functional coupling between cortex and STN
<span class='cite'>[<a href='indexli5.html#Xmallet_parkinsonian_2008'>223</a>, <a href='indexli5.html#Xmagill_brain_2004'>220</a>, <a href='indexli5.html#Xmoran_alterations_2011'>255</a>, <a href='indexli5.html#Xsharott_dopamine_2005'>325</a>, <a href='indexli5.html#Xlitvak_resting_2011'>212</a>, <a href='indexli5.html#Xstein_beta_2013'>337</a>]</span>, and that oscillatory activity in STN-GPe is contingent on
inputs from the cortex and can be abolished by disrupting them <span class='cite'>[<a href='indexli5.html#Xdrouot_functional_2004'>91</a>, <a href='indexli5.html#Xmagill_dopamine_2001'>221</a>, <a href='indexli5.html#Xtachibana_subthalamo-pallidal_2011'>343</a>]</span>. Cortical
patterning of the STN-GPe network by means of feedback inhibition provides a proposed
mechanism for this functional coupling <span class='cite'>[<a href='indexli5.html#Xbaufreton_enhancement_2005'>21</a>, <a href='indexli5.html#Xbevan_cellular_2006'>33</a>, <a href='indexli5.html#Xtachibana_subthalamo-pallidal_2011'>343</a>, <a href='indexli5.html#Xmallet_parkinsonian_2008'>223</a>, <a href='indexli5.html#Xmallet_dichotomous_2012'>225</a>]</span>. According to this
hypothesis, weak oscillatory activity entering the BG network via cortico-STN and/or
cortico-striatal afferents is amplified in the STN-GPe network when feedback inhibition
from the GPe is offset in phase with cortical excitation. Several mechanisms have
been hypothesized to contribute to the increased susceptibility of the STN-GPe
feedback loop to oscillatory entrainment after dopamine depletion. First, the increased
effectiveness of GPe IPSP in hyperpolarizing STN neurons leads to stronger
coupling of STN spikes to cortical EPSP, as a result of the higher availability of
<!-- l. 727 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'><mi mathvariant='italic'>Na</mi><mo class='MathClass-bin'>+</mo></math> and
<!-- l. 727 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'><mi>C</mi><msup><mrow><mi>a</mi></mrow><mrow><mn>2</mn><mo class='MathClass-bin'>+</mo></mrow></msup></math>
channels that enable low-latency responses and rebound spiking <span class='cite'>[<a href='indexli5.html#Xbaufreton_enhancement_2005'>21</a>, <a href='indexli5.html#Xhallworth_globus_2005'>140</a>, <a href='indexli5.html#Xhallworth_apamin-sensitive_2003'>141</a>, <a href='indexli5.html#Xotsuka_excitatory_2001'>272</a>]</span>. Second,
after DD both STN and GPe neurons undergo changes in ion channel expression that
decrease autonomous pacemaking and de-linearizes their current-firing rate response
<span class='cite'>[<a href='indexli5.html#Xloucif_depolarisation_2008'>214</a>, <a href='indexli5.html#Xzhu_pharmacological_2002'>384</a>, <a href='indexli5.html#Xmciver_chemogenetic_2018'>243</a>, <a href='indexli5.html#Xmciver_maladaptive_2019'>242</a>, <a href='indexli5.html#Xchan_hcn_2011'>56</a>]</span>. Finally, striatal iMSN become functionally decoupled from cortical
motor inputs through de-afferentiation and dendritic shrinkage and increase their spontaneous
activity: this decreases their ability to precisely interrupt GPe neuron activity and results in a
phase shift in GPe neuron spiking activity relative to CTX afferents to the STN
<span class='cite'>[<a href='indexli5.html#Xday_selective_2006'>75</a>, <a href='indexli5.html#Xbaufreton_enhancement_2005'>21</a>, <a href='indexli5.html#Xmallet_cortical_2006'>222</a>, <a href='indexli5.html#Xmallet_parkinsonian_2008'>223</a>, <a href='indexli5.html#Xmallet_dichotomous_2012'>225</a>]</span>. Feedback-mediated oscillations that are hypothesized to arise as a
result of these physiological changes have been observed in vivo <span class='cite'>[<a href='indexli5.html#Xpaz_rhythmic_2005'>280</a>]</span> and in slices
                                                                                

                                                                                
<span class='cite'>[<a href='indexli5.html#Xbaufreton_enhancement_2005'>21</a>]</span>. However, computational models have not yet been used to investigate how
pathological activity may arise as a result of the combined effect of such changes
in neurophysiology and cell morphology. Moreover, the ability of the network to
generate autonomous oscillations and its resonant response properties are still poorly
understood.
</p><!-- l. 746 --><p class='noindent'>
</p>
   <h3 class='sectionHead'><span class='titlemark'>2.4   </span> <a id='x7-270002.4'></a>Mechanism of action of DBS</h3>
<!-- l. 763 --><p class='noindent'>Despite its clinical success and widespread adoption, the mechanism of action of DBS remains
unclear, both at the cellular and network level (Fig. <a href='#x7-270014'>2.4<!-- tex4ht:ref: fig:dbs-local-effects  --></a>). At the cellular level, the interaction
of the electric field generated by the implanted electrode with the polarizable neuronal
membrane can produce complex effects depending on local electrical membrane properties,
neurite geometries and their orientation in the electric field <span class='cite'>[<a href='indexli5.html#Xranck_which_1975'>299</a>, <a href='indexli5.html#Xnowak_axons_1998'>265</a>, <a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>, <a href='indexli5.html#Xyousif_evaluating_2010'>377</a>]</span>. In addition,
the indirect effects resulting from the modulation of local neurochemistry through
neurotransmitter and gliotransmitter release are poorly understood <span class='cite'>[<a href='indexli5.html#Xmcintyre_deep_2016'>237</a>]</span>. The mechanism of
action at the network level is also unclear, with high-frequency spiking patterns in stimulated
neurons propagating both orthodromically and antidromically <span class='cite'>[<a href='indexli5.html#Xli_resonant_2007'>203</a>]</span> along the axons, affecting
synaptic filtering properties downstream <span class='cite'>[<a href='indexli5.html#Xrosenbaum_axonal_2014'>308</a>]</span>, and resulting in spike collision or somatic
invasion upstream <span class='cite'>[<a href='indexli5.html#Xli_therapeutic_2012'>202</a>, <a href='indexli5.html#Xkang_effects_2014'>175</a>]</span>.
</p>
   <figure class='figure'> 

                                                                                

                                                                                
<a id='x7-270014'></a>
                                                                                

                                                                                
<!-- l. 781 --><p class='noindent'><img alt='PIC' width='418' src='ch_background_literature/figs/JakobsLozano2018_CellularEffectsDBS_50pc.jpg' height='418' />
</p>
<figcaption class='caption'><span class='id'>Figure 2.4:</span><span class='content'><span class='cmbx-10x-x-109'>Factors contributing to net effects of DBS </span>by <span class='cite'>[<a href='indexli5.html#Xjakobs_cellular_2019'>165</a>]</span>, licensed under
<a href='https://creativecommons.org/licenses/by/4.0/'>CC-BY 4.0</a></span></figcaption><!-- tex4ht:label?: x7-270014  -->
                                                                                

                                                                                
   </figure>
<!-- l. 798 --><p class='indent'>   At the cellular level both excitatory and inhibitory responses have been observed in
stimulated neurons in response to DBS, mediated by different mechanisms. Stimulation of
local GABAergic and glutamergic afferents can produce both types of responses
<span class='cite'>[<a href='indexli5.html#Xlee_neurotransmitter_2004'>198</a>, <a href='indexli5.html#Xanderson_mechanisms_2004'>17</a>]</span>, including multiphasic ones <span class='cite'>[<a href='indexli5.html#Xbar-gad_complex_2004'>20</a>, <a href='indexli5.html#Xerez_short-term_2009'>95</a>, <a href='indexli5.html#Xmccairn_deep_2009'>234</a>, <a href='indexli5.html#Xkita_cortical_2011'>181</a>]</span>. Direct effects on the membrane
voltage can trigger spikes through the activation of voltage-gated Na channels <span class='cite'>[<a href='indexli5.html#Xmcintyre_deep_2016'>237</a>]</span>,
but can also cause depolarization block, and inactivation of ion channels over time
<span class='cite'>[<a href='indexli5.html#Xbeurrier_high-frequency_2001'>31</a>, <a href='indexli5.html#Xdo_sodium_2004'>86</a>, <a href='indexli5.html#Xshin_high_2007'>332</a>]</span>.
</p><!-- l. 808 --><p class='indent'>   Overall, the experimental evidence supports the hypothesis that the net effect of DBS on
somatic activity depends on the relative glutamate/GABA composition of activated axon
terminals on the target neurons <span class='cite'>[<a href='indexli5.html#Xchiken_mechanism_2016'>61</a>]</span>. In the STN, GABAergic synapses outweigh glutamergic
ones <span class='cite'>[<a href='indexli5.html#Xparent_functional_1995-1'>274</a>]</span> but they exhibit varying degrees of short-term depression or facilitation at different
time scales, which is engaged by high frequency stimulation <span class='cite'>[<a href='indexli5.html#Xatherton_short-term_2013'>19</a>, <a href='indexli5.html#Xfroux_d5_2018'>113</a>, <a href='indexli5.html#Xsteiner_connectivity_2019'>338</a>, <a href='indexli5.html#Xmilosevic_neuronal_2018'>249</a>]</span>. Differential
depression in combination with variability in the number of afferents activated during
stimulation and the unreliability of high-frequency recruitment <span class='cite'>[<a href='indexli5.html#Xzheng_axonal_2011'>382</a>, <a href='indexli5.html#Xrosenbaum_axonal_2014'>308</a>]</span> complicates making
straightforward predictions of the net effect of activation. Inhibitory synapses on STN neurons
were previously found to exhibit lower levels of depression during DBS compared to excitatory
synapses <span class='cite'>[<a href='indexli5.html#Xsteiner_connectivity_2019'>338</a>]</span>. Moreover, inhibitory currents mediated by metabotropic GABA<sub class='textsubscript'><span class='cmr-10'>B</span></sub>
receptors are enhanced by high-frequency coincident excitation of GABAergic afferents
<span class='cite'>[<a href='indexli5.html#Xbevan_cellular_2006'>33</a>]</span>, likely contributing to a net inhibitory effect of high-frequency DBS on STN
neurons. In support of this, recent experiments have shown that prolonged silent
periods in STN neurons are triggered by high-frequency stimulation (HFS) and that
the length of silent periods correlated with improved clinical outcome <span class='cite'>[<a href='indexli5.html#Xmilosevic_neuronal_2018'>249</a>]</span>. This
inhibition of STN somata was hypothesized to be caused by activation of GABA<sub class='textsubscript'><span class='cmr-10'>B</span></sub>
receptors <span class='cite'>[<a href='indexli5.html#Xmilosevic_neuronal_2018'>249</a>]</span> or by an altered balance of excitation and inhibition during DBS,
mediated by differential short-term depression of GABAergic and glutamergic synapses
<span class='cite'>[<a href='indexli5.html#Xsteiner_connectivity_2019'>338</a>]</span>.
</p><!-- l. 843 --><p class='indent'>   Consistent with these experimental observations computational models predict an
inhibitory effect of DBS on somatic spiking, mediated by activation of presynaptic terminals,
whereas axons are likely to become entrained to the HFS pulse train, dependent on their
orientation to and distance from the electrode <span class='cite'>[<a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>]</span>. This leads to a dissociation
between inputs and output in the STN, where the axonal outputs are overridden by a
constant-frequency pulse train with near-zero information content (‘information lesion’
                                                                                

                                                                                
hypothesis, <span class='cite'>[<a href='indexli5.html#Xgrill_deep_2004'>129</a>]</span>). Moreover, the terminals of stimulated axons can be driven to depression by
synaptic vesicle depletion as a result of high-frequency release, contributing to a disruption in
information transmission <span class='cite'>[<a href='indexli5.html#Xrosenbaum_axonal_2014'>308</a>]</span>. The information lesion is thought to be partial,
since action potentials are not triggered with 100% reliability in response to each
DBS pulse, and movement-related discharges are still observed in the target nuclei
<span class='cite'>[<a href='indexli5.html#Xagnesi_deep_2013'>9</a>, <a href='indexli5.html#Xzimnik_movement-related_2015'>385</a>]</span>.
</p><!-- l. 859 --><p class='indent'>   This high-frequency activation of efferents with ensuing synaptic effects downstream
seems to play an important role in establishing the therapeutic effects of DBS. An
optogenetic stimulation study in behaving rats showed that direct inhibition of STN
neurons had no effect on motor symptoms, whereas high frequency stimulation of
excitatory afferents reduced spiking of STN neurons and robustly improved motor
symptoms <span class='cite'>[<a href='indexli5.html#Xgradinaru_optical_2009'>126</a>]</span>. While direct high-frequency stimulation of STN somata was not
effective at improving symptoms in that study, the experiment was repeated in a
later study using faster opsin proteins, better at following high-frequency optical
activation, did find robust symptom improvement with 130 Hz direct stimulation
<span class='cite'>[<a href='indexli5.html#Xyu_frequency-specific_2020'>378</a>]</span>.
</p><!-- l. 873 --><p class='indent'>   Besides efferent axons, afferent axons to the stimulated nucleus are also entrained by
DBS, and antidromically traveling action potentials are believed to contribute to
network desynchronization and therapeutic effects of DBS <span class='cite'>[<a href='indexli5.html#Xli_resonant_2007'>203</a>, <a href='indexli5.html#Xli_therapeutic_2012'>202</a>]</span>. Antidromically
propagating action potentials have been observed in cortex-STN afferents <span class='cite'>[<a href='indexli5.html#Xli_resonant_2007'>203</a>]</span> and
there is indirect evidence that they are triggered in GPe-STN axons <span class='cite'>[<a href='indexli5.html#Xhashimoto_stimulation_2003'>146</a>, <a href='indexli5.html#Xagnesi_fidelity_2015'>10</a>]</span>. They
can collide with orthodromically traveling action potentials or invade the soma,
thereby altering spiking patterns in the upstream circuit. However it is not currently
understood how each of these effects contribute to the therapeutic effects of DBS
<span class='cite'>[<a href='indexli5.html#Xjakobs_cellular_2019'>165</a>]</span>.
</p>
   <h3 class='sectionHead'><span class='titlemark'>2.5   </span> <a id='x7-280002.5'></a>Approaches to computational modeling of the basal ganglia and DBS</h3>
<!-- l. 915 --><p class='noindent'>As outlined in Section <a href='#x7-260002.3.3'>2.3.3<!-- tex4ht:ref: sec:ch2-oscillation-mechanisms  --></a> - <a href='#x7-270002.4'>2.4<!-- tex4ht:ref: sec:ch2-dbs-mechanisms  --></a>, computational modeling is a valuable tool to investigate
brain dynamics at different spatial and temporal scales. Next to in vivo and in vitro
experimentation, it provides complementary methods to understand neuronal circuit
function and provide access to parameters that are difficult or impossible to measure
                                                                                

                                                                                
or alter in biological experiments. Moreover, by providing simultaneous access to
large numbers of variables that may span entire neuronal networks they provide
a means to discover complex interactions using large-scale multivariate analysis
techniques. When the aim is the design and optimization of deep brain stimulation
protocols, it has the additional benefit of offering a safe and cost-efficient environment
for implementing them compared to laboratory or clinical settings. In this way,
modeling can be used in concert with experimental data gathering in the iterative
process of generating model-driven predictions, experimental verification, and model
refinement.
</p><!-- l. 937 --><p class='indent'>   In the current section, an overview of different modeling approaches to investigate BG
network dysfunction and the effects of DBS will be presented. For the purpose of categorizing
computational modeling methods, several dimensions can be distinguished. One useful
dimension is the level of abstraction to describe neural systems, which is tightly related to the
spatial and temporal scale of phenomena described by the model equations. This
dimension ranges from detailed biophysical models of intracellular signaling and
membrane dynamics to mean field models of neural populations. At the lower end,
equations represent chemical reactions and transitions between structural conformations
in membrane-bound proteins, while at the upper end they represent fluctuations
in the mean firing rates or membrane potentials of entire neural populations. A
second useful dimension is the type of questions addressed using the model, on a
spectrum of mechanistic-physical questions to computational-cognitive questions about
brain function. At one end of this spectrum, mechanistic models focus on explaining
biophysical aspects of brain function such as the dynamics of neuronal spike generation, of
neurochemical reactions, and the generation of and interaction with extracellular
electric field. At the other end, computational-cognitive neuroscience models focus on
explaining the computations performed by the brain in support of cognitive function, and
the role of different anatomical pathways and connection patterns. Although these
dimensions are not entirely orthogonal, they form a useful guide to navigate the
landscape of modeling studies into brain function and basal ganglia function in
particular. Because the aims of this thesis include giving a mechanistic account of BG
pathophysiology and its interaction with DBS, the focus will be on models that cover these
questions.
                                                                                

                                                                                
</p><!-- l. 968 --><p class='noindent'>
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.5.1   </span> <a id='x7-290002.5.1'></a>Network models of pathological oscillations</h4>
<!-- l. 978 --><p class='noindent'>It is still unclear how exaggerated oscillations throughout BGTC networks seen in PD
and linked to motor symptoms are generated. While the modern view of the basal
ganglia shows the existence of multiple feedback loops within the network (Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>),
initial studies focused on the sub-network formed by the reciprocally connected
STN and GPe as a source of oscillatory activity. This was based on experimental
grounds, because experiments in tissue cultures showed an intrinsic ability to produce
synchronized, low-frequency (0.4-1.8 Hz) oscillatory bursting activity <span class='cite'>[<a href='indexli5.html#Xplenz_basal_1999'>287</a>]</span>, and
on theoretical grounds, due to the negative feedback structure of the STN-GPe
loop.
</p><!-- l. 988 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-300002.5.1'></a>Models of the STN-GPe network</h5>
<!-- l. 990 --><p class='noindent'>The same mechanism of oscillatory bursting, mediated by alternating phases of
excitation and inhibition and rebound bursting in the STN, was modeled using
single-compartment conductance-based neuron models by <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>]</span> and shown to generate
tremor-frequency oscillations (3-8 Hz). Successive models focused on the generation of
sub-beta and beta-band oscillations by the STN-GPe loop using mean field models
<span class='cite'>[<a href='indexli5.html#Xgillies_subthalamic-pallidal_2002'>119</a>, <a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xpavlides_improved_2012'>279</a>, <a href='indexli5.html#Xpasillas-lepine_delay-induced_2013'>277</a>, <a href='indexli5.html#Xdavidson_analysis_2016'>71</a>]</span>, and using spiking models <span class='cite'>[<a href='indexli5.html#Xpark_neural_2011'>276</a>, <a href='indexli5.html#Xkumar_role_2011'>191</a>, <a href='indexli5.html#Xmandali_spiking_2015'>227</a>, <a href='indexli5.html#Xmerrison-hort_emergence_2013'>246</a>, <a href='indexli5.html#Xahn_synchronized_2016'>11</a>, <a href='indexli5.html#Xwei_role_2015'>368</a>, <a href='indexli5.html#Xschwab_sparse_2016'>321</a>]</span>,
supported by the increasing evidence of a link between beta-band activity and PD motor
symptoms.
</p><!-- l. 999 --><p class='indent'>   The necessary conditions for the emergence of strong oscillatory activity in the
STN-GPe network have been reported in different computational studies as increased
reciprocal connection strength between the STN and GPe <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>, <a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xpavlides_improved_2012'>279</a>, <a href='indexli5.html#Xpark_neural_2011'>276</a>, <a href='indexli5.html#Xwei_role_2015'>368</a>]</span>,
increased striatal inhibition of the GPe <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>, <a href='indexli5.html#Xkumar_role_2011'>191</a>, <a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xvan_albada_mean-field_2009'>359</a>]</span> and the presence of
strong cortical excitation of the STN <span class='cite'>[<a href='indexli5.html#Xkumar_role_2011'>191</a>, <a href='indexli5.html#Xnevado-holgado_effective_2014'>263</a>]</span>. The latter two conditions work in a
synchrony-promoting manner by decreasing GPe firing rates, thereby increasing
the excitation:inhibition ratio in STN neurons and allowing for the build-up of an
excitatory phase in STN neurons, which is later interrupted by a wave of feedback
inhibition by the GPe. Some models additionally required intra-STN lateral excitation
                                                                                

                                                                                
for the loop to generate oscillations <span class='cite'>[<a href='indexli5.html#Xgillies_subthalamic-pallidal_2002'>119</a>, <a href='indexli5.html#Xmandali_spiking_2015'>227</a>]</span> although the experimental evidence
for this is mixed <span class='cite'>[<a href='indexli5.html#Xsteiner_connectivity_2019'>338</a>]</span>. Moreover, the role of intra-pallidal inhibition is unclear:
in the study of <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>]</span> strong lateral inhibition desynchronized activity in the loop
whereas lateral GPe-GPe inhibition measured experimentally is strengthened after
DD <span class='cite'>[<a href='indexli5.html#Xmiguelez_altered_2012'>248</a>, <a href='indexli5.html#Xwatanabe_presynaptic_2009'>366</a>]</span>. A spiking model of the STN-GPe network resolved this paradox by
suggesting that increased lateral inhibition might be counteracted by increased gap
junction-mediated connectivity between GPe neurons after DD <span class='cite'>[<a href='indexli5.html#Xschwab_sparse_2016'>321</a>]</span>, which has
some experimental support <span class='cite'>[<a href='indexli5.html#Xrash_immunogold_2000'>300</a>, <a href='indexli5.html#Xschwab_pallidal_2014'>320</a>, <a href='indexli5.html#Xphookan_gap_2015'>283</a>]</span>. Another explanation is provided by
a mean field model by <span class='cite'>[<a href='indexli5.html#Xliu_neural_2017'>213</a>]</span> where strong GPe lateral inhibition promotes upper
beta-band (21-35Hz) oscillations and weak inhibition favors lower beta-band (12-20Hz)
oscillations.
</p><!-- l. 1031 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-310002.5.1'></a>Extended BG network models</h5>
<!-- l. 1038 --><p class='noindent'>Other network models have placed the origin of beta-band and sub-beta oscillations in cortical
and thalamo-cortical circuits <span class='cite'>[<a href='indexli5.html#Xsherman_neural_2016'>330</a>, <a href='indexli5.html#Xpavlides_computational_2015'>278</a>, <a href='indexli5.html#Xreis_thalamocortical_2019'>306</a>, <a href='indexli5.html#Xliu_neural_2017'>213</a>]</span>, through interactions in the entire BGTC
network <span class='cite'>[<a href='indexli5.html#Xpavlides_computational_2015'>278</a>, <a href='indexli5.html#Xkumaravelu_biophysical_2016'>193</a>, <a href='indexli5.html#Xleblois_competition_2006'>196</a>, <a href='indexli5.html#Xkang_interaction_2013'>174</a>, <a href='indexli5.html#Xvan_albada_mean-field_2009'>359</a>]</span>, or locally in striatal or pallidostriatal circuits
<span class='cite'>[<a href='indexli5.html#Xmccarthy_striatal_2011'>235</a>, <a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>, <a href='indexli5.html#Xdamodaran_desynchronization_2015'>70</a>]</span>. In the thalamo-cortical origin hypothesis, beta-band activity originates through
reciprocal interactions between cortex and thalamus <span class='cite'>[<a href='indexli5.html#Xsherman_neural_2016'>330</a>, <a href='indexli5.html#Xreis_thalamocortical_2019'>306</a>]</span> which then resonates in the
STN-GPe feedback loop <span class='cite'>[<a href='indexli5.html#Xpavlides_computational_2015'>278</a>]</span>. Alternatively, oscillations arise through resonant interactions
between oscillations in the long loop through the hyperdirect pathway (CTX-STN-GPi-THA)
and in the STN-GPe loop <span class='cite'>[<a href='indexli5.html#Xkang_interaction_2013'>174</a>, <a href='indexli5.html#Xpavlides_computational_2015'>278</a>]</span>, as well as loops formed by the direct and
indirect pathway cortico-striatal projections <span class='cite'>[<a href='indexli5.html#Xvan_albada_mean-field_2009'>359</a>]</span>. The transient nature of beta-band
synchronization has also been investigated in several models <span class='cite'>[<a href='indexli5.html#Xpark_fine_2010'>275</a>, <a href='indexli5.html#Xpark_neural_2011'>276</a>, <a href='indexli5.html#Xsherman_neural_2016'>330</a>, <a href='indexli5.html#Xmirzaei_sensorimotor_2017'>252</a>]</span>. <span class='cite'>[<a href='indexli5.html#Xsherman_neural_2016'>330</a>]</span>
showed that transient beta-band oscillations in cortical magnetoencephalography data
could be explained in a cortical network model consisting of biophysically-based
multi-compartment neuron models as arising from the disruption of broad excitatory
drive to proximal dendrites of pyramidal neurons by strong distal drive over one
beta period. Sub-cortically, <span class='cite'>[<a href='indexli5.html#Xmirzaei_sensorimotor_2017'>252</a>]</span> showed that transient beta-band oscillations in the
STN-GPe network arose spontaneously when sensorimotor activity recorded from
rats was fed into the model through the hyperdirect and indirect pathways. In the
striatal origin hypothesis, a model by <span class='cite'>[<a href='indexli5.html#Xmccarthy_striatal_2011'>235</a>]</span> hypothesized that synchronized beta-band
                                                                                

                                                                                
oscillations arise from exaggerated collateral inhibition between striatal MSN that
inactivates intrinsic M-currents, leading to synchronized phases of excitation <span class='cite'>[<a href='indexli5.html#Xmccarthy_striatal_2011'>235</a>]</span>.
Subsequent models attributed the origin of beta band oscillations in the BG to the
synchronized interruption of iMSN neuron activity by inhibitory interneurons <span class='cite'>[<a href='indexli5.html#Xdamodaran_desynchronization_2015'>70</a>, <a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>]</span> which
facilitate the transfer of cortical beta-band oscillations between MSN <span class='cite'>[<a href='indexli5.html#Xbelic_interplay_2017'>26</a>]</span>, with
synchronization promoted by GPe-Striatal feedback through arkypallidal neurons
<span class='cite'>[<a href='indexli5.html#Xcorbit_pallidostriatal_2016'>67</a>]</span>.
</p><!-- l. 1083 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-320002.5.1'></a>Parameter sensitivity of oscillations</h5>
<!-- l. 1086 --><p class='noindent'>The oscillation frequency of (sub-loops of) the BGTC network has been shown to be sensitive
to different model parameters in previous computational models. In mean field models of the
STN-GPe loop the oscillation frequency showed a strong sensitivity to transmission delays and
neuronal membrane time constants <span class='cite'>[<a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xlienard_beta-band_2017'>204</a>]</span>, and a weaker sensitivity to coupling strengths
<span class='cite'>[<a href='indexli5.html#Xholgado_conditions_2010'>154</a>, <a href='indexli5.html#Xpavlides_computational_2015'>278</a>, <a href='indexli5.html#Xliu_neural_2017'>213</a>]</span>, also demonstrated in a spiking model <span class='cite'>[<a href='indexli5.html#Xwei_role_2015'>368</a>]</span>. One way that disparate findings
in terms of transmission delays and the emergent oscillations can be reconciled is by noting the
difference between effective transmission delays in different modeling frameworks.
In a biophysically detailed model for example, the effective transmission delay is
the sum of the axonal propagation delay, synaptic release and binding delays, and
dendritic integration time <span class='cite'>[<a href='indexli5.html#Xkumar_role_2011'>191</a>]</span>. In single compartment neuron models, the dendritic
integration time is absent, whereas in mean-field models commonly only an axonal
propagation time is included. Furthermore, the ’coupling strengths’ that determine the
amount of excitation or inhibition that a neuronal population receives from the source
population of a projection are determined by different factors, further confounding
comparisons between models. Next to the synaptic weights (peak synaptic conductance in
conductance-based models), the background firing rate of the source population, and the
relative amount of afferents from the source population compared to other sources on
the target neurons all determine the effective coupling strengths between neuronal
populations.
</p><!-- l. 1112 --><p class='noindent'>
                                                                                

                                                                                
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.5.2   </span> <a id='x7-330002.5.2'></a>Modeling DBS mechanisms of action</h4>
<!-- l. 1137 --><p class='noindent'>Various modeling approaches have been used to investigate the mechanisms of action of DBS,
depending on the nature of the questions addressed. To study the local effects of cellular and
axonal stimulation by DBS, models of the electric field surrounding the electrode lead during
DBS have been coupled to multi-compartment neuronal cable models (field-cable models)
<span class='cite'>[<a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmcintyre_electric_2004'>241</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>, <a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>, <a href='indexli5.html#Xyousif_evaluating_2010'>377</a>, <a href='indexli5.html#Xyousif_spatiotemporal_2012'>376</a>, <a href='indexli5.html#Xkang_effects_2014'>175</a>, <a href='indexli5.html#Xanderson_action_2018'>16</a>]</span>. Some studies have also combined this method
applied to a subset of neurons represented by cable models with other neurons represented by
single-compartment models in order to study the network effects of DBS <span class='cite'>[<a href='indexli5.html#Xkang_effects_2014'>175</a>, <a href='indexli5.html#Xanderson_action_2018'>16</a>]</span>.
However, typically simplifications are made in modeling the effect of DBS on neuronal
activity when investigating the network effects of DBS or the spatial extent of axonal
activation.
</p><!-- l. 1153 --><p class='indent'>   Building on detailed electric field models, driving force models approximate the
driving force exerted by the electric field on neuronal membrane voltages by a single
membrane current per compartment that is a spatial function of the electric field
<span class='cite'>[<a href='indexli5.html#Xrattay_basic_1999'>301</a>, <a href='indexli5.html#Xwarman_modeling_1992'>365</a>, <a href='indexli5.html#Xpeterson_predicting_2011'>281</a>]</span>. The simplest formulation is the <span class='cmti-10x-x-109'>activating function </span>method where
the driving force is equal to the second spatial derivative of the electric field along
a neurite element<span class='cite'>[<a href='indexli5.html#Xrattay_basic_1999'>301</a>]</span>. This result is derived from the cable equation, where the
second spatial derivative of the field is equal to the direct contribution of the field to
membrane depolarization. Driving force models allow representing the effect of DBS
by equivalent intracellular current sources that are derived from detailed electric
field models without modifying the typical cable equations to include additional
extracellular layers. This results in higher computational efficiency in solving the cable
equations, so that computational resources can be directed towards simulating larger
networks. Network models making use of single-compartment neuron models commonly
resort to a more drastic simplification where the driving force on the membrane
voltage is a membrane current that is directly proportional to the applied electrode
current <span class='cite'>[<a href='indexli5.html#Xfeng_optimal_2007'>103</a>, <a href='indexli5.html#Xrubin_high_2004'>312</a>, <a href='indexli5.html#Xhahn_modeling_2010'>139</a>, <a href='indexli5.html#Xpirini_computational_2009'>285</a>, <a href='indexli5.html#Xkang_interaction_2013'>174</a>, <a href='indexli5.html#Xkumaravelu_biophysical_2016'>193</a>]</span>. The motivation for this simplification is that
the net effect of DBS on a multi-compartment, spatially extended cable neuron
model may be represented by a single equivalent current if the neuron dynamics is
lumped together in a single compartment. However, the dependence of this equivalent
current on the geometry and biophysics of the extended model is typically not taken
into account. An alternative method that is commonly used to simulate DBS in
                                                                                

                                                                                
network models is to deliver stimulus-locked spikes to synapses at axon terminals
that are assumed to be stimulated <span class='cite'>[<a href='indexli5.html#Xhahn_modeling_2010'>139</a>, <a href='indexli5.html#Xguo_thalamocortical_2008'>135</a>, <a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>]</span>. However these methods do
not allow the effect of variations in the amplitude of the applied electric field to be
examined.
</p><!-- l. 1185 --><p class='indent'>   Finally, mean field models of neuronal populations are commonly used for the
design and testing of DBS control algorithms because of their ease of analysis due to
the low number of state variables, analytical tractability, and low computational
complexity.
</p><!-- l. 1191 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-340002.5.2'></a>Models of isolated neuronal activation</h5>
<!-- l. 1198 --><p class='noindent'>One strand of research has focused on quantifying the extent of neuronal activation around the
DBS electrode, and how subcellular neuronal elements respond to DBS. The focus in these
studies is not on the network effects of DBS, but rather on the relation between
stimulus parameters, electrode geometry, and the spatial extent over which different
neuronal elements are activated by DBS. These questions are typically addressed using
field-cable and driving force models, and using predictors trained using these models
<span class='cite'>[<a href='indexli5.html#Xgunalan_quantifying_2018'>132</a>]</span>.
</p><!-- l. 1206 --><p class='indent'>   A common first step in field-cable models and driving force models is to calculate the
electric field in the tissue surrounding the DBS electrode. This is done using volume conductor
models, which can take either an analytical form or are solved numerically, using finite element
modeling (FEM) techniques. Volume conductor models have been widely used to show how
the field distribution during DBS is affected by the electrode placement and geometry,
properties of the electrode-tissue interface, and heterogeneous and anisotropic electrical
properties of brain tissue and how this affects the spatial extent of neural elements activated
<span class='cite'>[<a href='indexli5.html#Xbossetti_analysis_2008'>39</a>, <a href='indexli5.html#Xbutson_tissue_2005'>49</a>, <a href='indexli5.html#Xgrant_effect_2010'>127</a>, <a href='indexli5.html#Xschmidt_single_2013'>317</a>, <a href='indexli5.html#Xschmidt_single_2013'>317</a>, <a href='indexli5.html#Xhowell_role_2017'>158</a>, <a href='indexli5.html#Xastrom_influence_2012'>1</a>]</span>
</p><!-- l. 1218 --><p class='indent'>   Field-cable and driving force models of extracellular stimulation revealed that axons are
the primary targets for direct activation by DBS rather than somatic and dendritic elements
<span class='cite'>[<a href='indexli5.html#Xnowak_axons_1998'>265</a>, <a href='indexli5.html#Xnowak_axons_1998-1'>266</a>, <a href='indexli5.html#Xmcintyre_excitation_1999'>238</a>, <a href='indexli5.html#Xmcintyre_selective_2000'>239</a>, <a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmcintyre_electric_2004'>241</a>, <a href='indexli5.html#Xyousif_spatiotemporal_2012'>376</a>]</span>. The influence on somatic activity in BG neurons is
generally inhibitory, reducing the background firing rate but rarely resulting in complete
inhibition <span class='cite'>[<a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>, <a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>]</span>. These studies show that inhibition is primarily an indirect effect
mediated by the activation of inhibitory pre-synaptic terminals that are more densely
                                                                                

                                                                                
distributed close to the soma compared to excitatory terminals. Besides the influence of
synaptic activation, stimulation of the dendrites and soma can also cause changes in somatic
background activity through the activation of voltage-gated ion channels <span class='cite'>[<a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>, <a href='indexli5.html#Xrattay_which_2010'>302</a>, <a href='indexli5.html#Xyousif_evaluating_2010'>377</a>, <a href='indexli5.html#Xyousif_spatiotemporal_2012'>376</a>]</span>.
The observed inhibitory effect of DBS is generally calculated with respect to the baseline
firing rate without DBS, and does not exclude the occurrence of stimulus-locked
firing in somata. For example, in a model of GPi DBS that included variability
in cell positioning, activation of excitatory and inhibitory synapses, and dendritic
voltage-gated channels, mixed effects were seen with 42% of cells showing mild to
strong somatic stimulus-locking and 57% showing complete or partial inhibition
<span class='cite'>[<a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>]</span>.
</p><!-- l. 1239 --><p class='indent'>   Field-cable models are also used to build estimators of the volume of tissue where axons
are activated by DBS (VTA). In the original formulation, axonal cable models without cell
bodies attached were positioned perpendicularly to the electrode in a rectangular grid, and the
volume containing axons where action potentials were triggered was calculated for a specific
set of DBS parameters <span class='cite'>[<a href='indexli5.html#Xbutson_role_2006'>50</a>]</span>. By first calculating threshold values for the driving force required
to activate axons, this method can be used to rapidly calculate regions of activation and
explore stimulus parameters without solving the extended, multi-layer cable equations
<span class='cite'>[<a href='indexli5.html#Xbutson_role_2006'>50</a>, <a href='indexli5.html#Xbutson_patient-specific_2007'>48</a>]</span>. Moreover, different classes of predictors such as artificial neural networks
(ANN) can be trained on FC-based VTA to further speed up this process <span class='cite'>[<a href='indexli5.html#Xchaturvedi_artificial_2013'>57</a>]</span>. In
combination with VTA methods, the estimation of electrical tissue properties based on
magnetic resonance imaging (MRI) data enables the use of VTA predictions on a
patient-specific basis <span class='cite'>[<a href='indexli5.html#Xbutson_patient-specific_2007'>48</a>, <a href='indexli5.html#Xastrom_method_2009'>2</a>]</span>. This allows direct use of VTA models in the clinic
for DBS lead positioning and stimulation parameters selection, with the goal of
activating targeted axon bundles and minimizing the activation of other structures
<span class='cite'>[<a href='indexli5.html#Xsakas_stimexplorer_2007'>47</a>, <a href='indexli5.html#Xsakas_cicerone_2007'>251</a>, <a href='indexli5.html#Xfrankemolle_reversing_2010'>111</a>, <a href='indexli5.html#Xnoecker_stimvision_2018'>264</a>]</span>.
</p><!-- l. 1263 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-350002.5.2'></a>Spiking network models of DBS</h5>
<!-- l. 1271 --><p class='noindent'>In parallel with models of isolated neurons, network models of biophysically-based spiking
neuron models have been used extensively to study the network effects of DBS. In the original
dual pathway model of the BG by <span class='cite'>[<a href='indexli5.html#Xalbin_functional_1989'>13</a>]</span> (Fig. <a href='#x7-180013'>2.3<!-- tex4ht:ref: fig:bg_pathways-projections  --></a>.A), the effect of DBS was initially
understood as a silencing of the STN that had become overactive as a result of
                                                                                

                                                                                
increased striatal inhibition of the GPe in the indirect pathway <span class='cite'>[<a href='indexli5.html#Xlittle_computational_2015'>209</a>]</span>. However, based on
the later findings of somatic-axonal decoupling and axonal entrainment by DBS
<span class='cite'>[<a href='indexli5.html#Xhashimoto_stimulation_2003'>146</a>, <a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>]</span> this interpretation was hard to maintain, as STN DBS would lead to
increased excitation of the GPi. This paradox can be resolved by recent findings
demonstrating profound short-term depression (STD) at axon terminals entrained by HFS
DBS <span class='cite'>[<a href='indexli5.html#Xrosenbaum_axonal_2014'>308</a>]</span>, demonstrating that the dual pathway model is still useful for reasoning
about BG activity. Later network modeling studies have taken various approaches at
explaining the network effects of different DBS protocols, which can be distinguished
based on the biomarkers that they attempt to control or restore to pre-parkinsonian
levels.
</p>
<!-- l. 1289 --><p class='noindent'><span class='paragraphHead'><a id='x7-360002.5.2'></a><span class='cmbx-10x-x-109'>Thalamic relay fidelity</span></span>
   An early strand of modeling studies focused on regularizing the exaggerated
bursting activity in the GPi that is transmitted to thalamic neurons and is thought to
impair their ability to faithfully relay information (thalamic relay fidelity biomarker,
<span class='cite'>[<a href='indexli5.html#Xrubin_high_2004'>312</a>, <a href='indexli5.html#Xfeng_optimal_2007'>103</a>, <a href='indexli5.html#Xguo_thalamocortical_2008'>135</a>, <a href='indexli5.html#Xpirini_computational_2009'>285</a>, <a href='indexli5.html#Xhahn_modeling_2010'>139</a>, <a href='indexli5.html#Xguo_multi-site_2011'>134</a>]</span>). This was first demonstrated by <span class='cite'>[<a href='indexli5.html#Xrubin_high_2004'>312</a>]</span> in an extended version
of the <span class='cite'>[<a href='indexli5.html#Xterman_activity_2002'>349</a>]</span> model that included the GPi and a thalamic population. In this model, STN DBS
restored the ability of thalamic neurons to relay excitatory sensimotor input by eliminating
oscillatory bursting inputs from the GPi that disrupted it. The same model was used to
investigate the effectiveness of alternative DBS stimulation patterns <span class='cite'>[<a href='indexli5.html#Xfeng_optimal_2007'>103</a>]</span> and to study the
influence of DBS on thalamic relay fidelity using experimentally recorded GPi spiking patterns
recorded from parkinsonian monkeys <span class='cite'>[<a href='indexli5.html#Xguo_thalamocortical_2008'>135</a>]</span>. In a subsequent study by <span class='cite'>[<a href='indexli5.html#Xhahn_modeling_2010'>139</a>]</span> this model was
further extended to include cortical beta-band activity to the STN-GPe loop, and
the network parameters were fitted to match in vivo recordings of parkinsonian
monkeys. Moreover, STN DBS was simulated using the updated view that STN
efferents were entrained and somata received sub-threshold current pulses due to
antidromic activation <span class='cite'>[<a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>]</span>. The results showed how GPi bursting was reduced in a
frequency-dependent manner, and dependent on the volume of STN neurons activated by
DBS.
</p>
                                                                                

                                                                                
<!-- l. 1311 --><p class='noindent'><span class='paragraphHead'><a id='x7-370002.5.2'></a><span class='cmbx-10x-x-109'>Pathological oscillations</span></span>
   Another class of models has focused on quantifying the suppression of pathological
oscillatory activity in specific frequency bands associated with the motor symptoms of PD
<span class='cite'>[<a href='indexli5.html#Xkumar_role_2011'>191</a>, <a href='indexli5.html#Xkang_interaction_2013'>174</a>, <a href='indexli5.html#Xkang_effects_2014'>175</a>, <a href='indexli5.html#Xkumaravelu_biophysical_2016'>193</a>, <a href='indexli5.html#Xholt_phasic_2016'>156</a>, <a href='indexli5.html#Xpopovych_pulsatile_2017'>289</a>, <a href='indexli5.html#Xanderson_action_2018'>16</a>]</span>. <span class='cite'>[<a href='indexli5.html#Xkumar_role_2011'>191</a>]</span> simulated DBS in the STN-GPe network in two
distinct ways and quantified the effect on the power spectrum of STN population activity, and
a derived synchronization index. When DBS was simulated as periodic blanking of
excitatory inputs to the STN, at least 50% of STN neurons had to be stimulated at
<!-- l. 1318 --><math xmlns='http://www.w3.org/1998/Math/MathML' display='inline'> <mo class='MathClass-rel'>&gt;</mo></math> 100
Hz to quench oscillatory activity but strong harmonics of the stimulation frequency were
introduced in the spectrum. When DBS was approximated as periodic synaptic inhibition,
oscillations were also quenched at higher stimulation frequencies but no strong harmonics were
introduced. <span class='cite'>[<a href='indexli5.html#Xkang_interaction_2013'>174</a>]</span> simulated the emergence of beta-band oscillations in a closed-loop
model of the BGTC network as a result of the interaction of low-frequency (1.3 Hz)
oscillations in the STN-GPe loop and higher frequency (30 Hz) firing in the cortex, as the
strength of the hyperdirect pathway projection was increased. Their model showed a
reduction in oscillatory power at both beta-band and tremor frequencies as the DBS
frequency was increased, but strengthening of beta-band oscillations through resonance
when the DBS frequency fell in this range. A similar closed-loop model consisting of
single-compartment conductance-based neuron models was investigated by <span class='cite'>[<a href='indexli5.html#Xkumaravelu_biophysical_2016'>193</a>]</span>. They also
demonstrated frequency-dependent suppression of oscillations, but both in the alpha and
beta band, for DBS frequencies greater than 50 Hz. A noteworthy features of their
model was that it reproduced multi-phasic responses obtained experimentally by
<span class='cite'>[<a href='indexli5.html#Xkita_cortical_2011'>181</a>]</span> using cortical microstimulation. <span class='cite'>[<a href='indexli5.html#Xholt_phasic_2016'>156</a>]</span> demonstrated the effectiveness of an
alternative closed-loop stimulation protocol in the network model of <span class='cite'>[<a href='indexli5.html#Xhahn_modeling_2010'>139</a>]</span>. They
show that DBS pulses applied with a fixed phase relationship to the ongoing beta
oscillation can suppress oscillations, and that suppressing phase relationships can be
predicted from population phase response curves. Moreover, they show that beta-band
suppression can be achieved using lower pulse amplitudes compared to HFS DBS, and
that phasic stimulation using bursts of pulses is more effective than single-pulse
stimulation.
</p>
<!-- l. 1346 --><p class='noindent'><span class='paragraphHead'><a id='x7-380002.5.2'></a><span class='cmbx-10x-x-109'>Functional responses</span></span>
                                                                                

                                                                                
   A third class of network models attempts to relate the efficacy of DBS to its ability
to restore functional responses related to motor processing and decision making
<span class='cite'>[<a href='indexli5.html#Xfrank_hold_2007'>110</a>, <a href='indexli5.html#Xsantaniello_closed-loop_2011'>316</a>, <a href='indexli5.html#Xkumar_role_2011'>191</a>, <a href='indexli5.html#Xhumphries_network_2012'>160</a>, <a href='indexli5.html#Xmandali_probing_2016'>226</a>]</span>. <span class='cite'>[<a href='indexli5.html#Xhumphries_network_2012'>160</a>]</span> investigated the effect of DBS in a network of integrate-and-fire
neurons connected topographically in segregated ‘channels’ designed to mimic the generation
of motor-related responses. They showed that STN DBS, simulated using an intracellular
current source, restored a mix of excitatory and inhibitory responses in different GPi output
neurons similar to the situation before dopaminergic lesion. <span class='cite'>[<a href='indexli5.html#Xmandali_probing_2016'>226</a>]</span> trained a network of
Izhikevich-type neurons to perform a probabilistic learning task using reinforcement learning
techniques and investigated the effect of DBS on the learned behaviors. They found that
STN DBS could shift the selection bias of learned behaviors from a reward-based to
punishment-based bias depending on the electrode position, and that reaction times were
lower during high conflict decisions, defined as providing equal rewards for multiple
outcomes.
</p><!-- l. 1364 --><p class='noindent'>
</p>
   <h5 class='subsubsectionHead'><a id='x7-390002.5.2'></a>Mean field models of DBS</h5>
<!-- l. 1372 --><p class='noindent'>As an alternative to networks of single-compartment neuron models, mean-field models of
neuronal population activity <span class='cite'>[<a href='indexli5.html#Xdeco_dynamic_2008'>79</a>]</span> have been used extensively to study DBS protocols, and in
particular those that aim to desynchronize neuronal population activity and/or suppress
oscillatory activity.
</p><!-- l. 1379 --><p class='indent'>   The mechanism of action of open-loop high-frequency DBS has been studied in mean-field
models of the oscillating STN-GPe loop using methods based on control theory in <span class='cite'>[<a href='indexli5.html#Xde_paor_analysis_2009'>76</a>, <a href='indexli5.html#Xdavidson_application_2014'>72</a>, <a href='indexli5.html#Xdavidson_analysis_2016'>71</a>]</span>.
In these models, the mean-field of each population is represented by a second order linear
transfer function with a sigmoidal nonlinearity at its input, and the two populations are
reciprocally connected in series in closed-loop fashion. The DBS input to the STN is
combined with the sigmoidal nonlinearity into an equivalent nonlinearity in order to
make the system amenable to the derivation of analytical relationships between
DBS amplitude and frequency, and oscillation amplitudes <span class='cite'>[<a href='indexli5.html#Xdavidson_application_2014'>72</a>]</span>. Another approach to
open-loop control is <span class='cmti-10x-x-109'>coordinated reset </span>neuromodulation where oscillating populations are
desynchronized by applying temporally and spatially coordinated pulses to subsets of the
populations <span class='cite'>[<a href='indexli5.html#Xtass_model_2003'>345</a>]</span>. This type of stimulation has been applied in models using spike-timing
dependent plasticity (STDP) to demonstrate that it can cause pathologically strong
                                                                                

                                                                                
synaptic interactions to be unlearned, with long-lasting effects after stimulation offset
<span class='cite'>[<a href='indexli5.html#Xtass_long-term_2006'>346</a>]</span>.
</p><!-- l. 1406 --><p class='indent'>   A large number of studies have also used mean-field models to investigate closed-loop DBS
protocols. <span class='cite'>[<a href='indexli5.html#Xrosenblum_controlling_2004'>310</a>, <a href='indexli5.html#Xrosenblum_delayed_2004'>309</a>]</span> introduced a closed-loop control scheme where the mean field was fed
back as an input to individual neurons, represented as oscillators, with an appropriate delay
and amplification. This caused the neurons to desynchronize, abolishing the mean field
oscillation but not individual neuron’s oscillatory activity. Control using feedback of the
mean-field was later extended using nonlinear transformations applied to the mean-field to
improve robustness of the controllers and combined with multi-site stimulation as in
coordinated reset DBS <span class='cite'>[<a href='indexli5.html#Xhauptmann_effectively_2005'>147</a>, <a href='indexli5.html#Xpopovych_effective_2005'>288</a>, <a href='indexli5.html#Xpyragas_controlling_2007'>293</a>, <a href='indexli5.html#Xluo_washout_2009'>216</a>, <a href='indexli5.html#Xpopovych_synchronization_2010'>290</a>]</span>.
</p><!-- l. 1418 --><p class='noindent'>
</p>
   <h4 class='subsectionHead'><span class='titlemark'>2.5.3   </span> <a id='x7-400002.5.3'></a>Limitations of computational models</h4>
<!-- l. 1419 --><p class='noindent'>Each of the modeling approaches discussed above has its own merits and is suitable for
investigating distinct aspects of the mechanism of activation by DBS, either at the subcellular
level, on neuronal tissues at macroscopic scales, or on neuronal network activity. However,
detailed biophysical models typically focus on isolated neurons with synaptic inputs
represented by spike sources determined by making a priori assumptions about afferent
activation <span class='cite'>[<a href='indexli5.html#Xmcintyre_cellular_2004'>236</a>, <a href='indexli5.html#Xmiocinovic_computational_2006'>250</a>, <a href='indexli5.html#Xjohnson_quantifying_2008'>168</a>]</span>. Hence, neuronal activity patterns do not reflect those when the
neuron is embedded in a network and is affected by synchronized patterns of activity that
arise as as a result of the collective network dynamics. Network models on the other hand are
suitable to investigate emergent phenomena but typically make a priori assumptions about
which neuronal elements are activated or inhibited by DBS. Moreover, they often neglect
heterogeneity in activation patterns that may occur because of spatial proximity to the
electrode, or differential activation along the cell structure as a result of its placement in
the electric field. Instead, DBS is typically modeled as an intracellular current in
single-compartment cell models and volume conduction effects of the surrounding tissue is not
taken into account. The influence of DBS amplitude and pulse duration is therefore
not captured in a biophysically correct manner. No models of BG DBS currently
exist that simultaneously take into account subcellular and distributed effects of
neuronal activation, and network interactions that are influenced by the propagation of
                                                                                

                                                                                
stimulus-induced spikes both orthodromically and antidromically away from the stimulated
nucleus.
</p><!-- l. 1447 --><p class='indent'>   In the next two chapters, a network model will be developed that combines these features
into a single network model so that distributed effects of DBS can be studies at the network
scale.
                                                                                

                                                                                
</p>
   <!-- l. 226 --><div class='crosslinks'><p class='noindent'>[<a href='indexch3.html'>next</a>] [<a href='indexch1.html'>prev</a>] [<a href='indexch1.html#tailindexch1.html'>prev-tail</a>] [<a href='indexch2.html'>front</a>] [<a href='index.html#indexch2.html'>up</a>] </p></div>
<!-- l. 226 --><p class='indent'>   <a id='tailindexch2.html'></a>   </p> 
</body> 
</html>